Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Matthew Harrison is an analyst at Morgan Stanley. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/19/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/17/2025 | LEGN | Buy Now | Legend Biotech | $38.39 | 108.38% | Matthew Harrison60% | $82 → $80 | Maintains | Overweight | Get Alert |
| 03/14/2025 | TSVT | Buy Now | 2seventy bio | $4.96 | 0.81% | Matthew Harrison60% | $6 → $5 | Maintains | Equal-Weight | Get Alert |
| 03/12/2025 | TNYA | Buy Now | Tenaya Therapeutics | $0.67 | 643.38% | Matthew Harrison60% | $15 → $5 | Maintains | Overweight | Get Alert |
| 03/11/2025 | GILD | Buy Now | Gilead Sciences | $106.96 | 21.54% | Matthew Harrison60% | $123 → $130 | Maintains | Overweight | Get Alert |
| 03/07/2025 | DNLI | Buy Now | Denali Therapeutics | $14.51 | 127.43% | Matthew Harrison60% | $41 → $33 | Assumes | → Overweight | Get Alert |
| 02/13/2025 | BIIB | Buy Now | Biogen | $143.09 | 9.72% | Matthew Harrison60% | $192 → $157 | Maintains | Equal-Weight | Get Alert |
| 02/12/2025 | GILD | Buy Now | Gilead Sciences | $106.96 | 15% | Matthew Harrison60% | $113 → $123 | Maintains | Overweight | Get Alert |
| 02/11/2025 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | -10.39% | Matthew Harrison60% | $450 → $459 | Maintains | Equal-Weight | Get Alert |
| 02/06/2025 | INSM | Buy Now | Insmed | $76.99 | 16.9% | Matthew Harrison60% | $85 → $90 | Maintains | Overweight | Get Alert |
| 01/15/2025 | MRNA | Buy Now | Moderna | $33.70 | 12.76% | Matthew Harrison60% | $70 → $38 | Maintains | Equal-Weight | Get Alert |
| 01/10/2025 | GILD | Buy Now | Gilead Sciences | $106.96 | 5.65% | Matthew Harrison60% | $87 → $113 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 11/26/2024 | ALEC | Buy Now | Alector | $1.32 | 127.27% | Matthew Harrison60% | $10 → $3 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 11/05/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | -7.07% | Matthew Harrison60% | $473 → $476 | Maintains | Equal-Weight | Get Alert |
| 11/01/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | 78.06% | Matthew Harrison60% | $1235 → $1184 | Maintains | Overweight | Get Alert |
| 10/31/2024 | BIIB | Buy Now | Biogen | $143.09 | 42.57% | Matthew Harrison60% | $285 → $204 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 10/01/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | -7.46% | Matthew Harrison60% | $462 → $474 | Maintains | Equal-Weight | Get Alert |
| 09/16/2024 | IOBT | Buy Now | IO Biotech | $0.90 | 566% | Matthew Harrison60% | $4 → $6 | Maintains | Overweight | Get Alert |
| 09/03/2024 | IOBT | Buy Now | IO Biotech | $0.90 | 344% | Matthew Harrison60% | $7 → $4 | Maintains | Overweight | Get Alert |
| 08/13/2024 | AVIR | Buy Now | Atea Pharmaceuticals | $3.17 | 117.03% | Matthew Harrison60% | $2 → $6.88 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 07/29/2024 | TSVT | Buy Now | 2seventy bio | $4.96 | 20.97% | Matthew Harrison60% | $7 → $6 | Maintains | Equal-Weight | Get Alert |
| 07/12/2024 | INSM | Buy Now | Insmed | $76.99 | 10.4% | Matthew Harrison60% | $60 → $85 | Maintains | Overweight | Get Alert |
| 07/11/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | -11.17% | Matthew Harrison60% | $402 → $455 | Maintains | Equal-Weight | Get Alert |
| 07/11/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | 77.76% | Matthew Harrison60% | $1183 → $1182 | Maintains | Overweight | Get Alert |
| 06/24/2024 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | 173.52% | Matthew Harrison60% | $165 → $200 | Maintains | Overweight | Get Alert |
| 06/21/2024 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | 125.66% | Matthew Harrison60% | $165 → $165 | Reiterates | Overweight → Overweight | Get Alert |
| 06/21/2024 | CNTA | Buy Now | Centessa Pharmaceuticals | $16.51 | -33.37% | Matthew Harrison60% | $8 → $11 | Maintains | Equal-Weight | Get Alert |
| 06/18/2024 | ZNTL | Buy Now | Zentalis Pharma | $1.79 | 346.93% | Matthew Harrison60% | $38 → $8 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 05/28/2024 | INSM | Buy Now | Insmed | $76.99 | -22.07% | Matthew Harrison60% | $43 → $60 | Maintains | Overweight | Get Alert |
| 05/28/2024 | ARGX | Buy Now | argenx | $610.00 | -16.39% | Matthew Harrison60% | $515 → $510 | Maintains | Overweight | Get Alert |
| 05/10/2024 | INSM | Buy Now | Insmed | $76.99 | -44.15% | Matthew Harrison60% | $40 → $43 | Maintains | Overweight | Get Alert |
| 05/09/2024 | EDIT | Buy Now | Editas Medicine | $1.35 | 418.52% | Matthew Harrison60% | → $7 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 04/26/2024 | GILD | Buy Now | Gilead Sciences | $106.96 | -27.07% | Matthew Harrison60% | $80 → $78 | Maintains | Equal-Weight | Get Alert |
| 04/26/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 56.53% | Matthew Harrison60% | $115 → $112 | Maintains | Overweight | Get Alert |
| 04/22/2024 | PHVS | Buy Now | Pharvaris | $15.96 | 113.03% | Matthew Harrison60% | $34 → $34 | Maintains | Overweight | Get Alert |
| 04/15/2024 | PHVS | Buy Now | Pharvaris | $15.96 | 113.03% | Matthew Harrison60% | $35 → $34 | Maintains | Overweight | Get Alert |
| 03/26/2024 | GMAB | Buy Now | Genmab | $20.20 | 58.42% | Matthew Harrison60% | $32 → $32 | Maintains | Underweight | Get Alert |
| 03/13/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | 67.68% | Matthew Harrison60% | $1104 → $1115 | Maintains | Overweight | Get Alert |
| 12/07/2023 | PHVS | Buy Now | Pharvaris | $15.96 | 119.3% | Matthew Harrison60% | $32 → $35 | Maintains | Overweight | Get Alert |
| 11/30/2023 | ARGX | Buy Now | argenx | $610.00 | -3.93% | Matthew Harrison60% | $607 → $586 | Maintains | Overweight | Get Alert |
| 11/14/2023 | PHVS | Buy Now | Pharvaris | $15.96 | 100.5% | Matthew Harrison60% | $34 → $32 | Maintains | Overweight | Get Alert |
| 11/10/2023 | BIIB | Buy Now | Biogen | $143.09 | 160.68% | Matthew Harrison60% | $361 → $373 | Maintains | Overweight | Get Alert |
| 11/09/2023 | GMAB | Buy Now | Genmab | $20.20 | 58.42% | Matthew Harrison60% | $33 → $32 | Maintains | Underweight | Get Alert |
| 11/08/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | -28.94% | Matthew Harrison60% | $359 → $364 | Maintains | Equal-Weight | Get Alert |
| 11/07/2023 | ZNTL | Buy Now | Zentalis Pharma | $1.79 | 2022.91% | Matthew Harrison60% | $55 → $38 | Maintains | Overweight | Get Alert |
| 11/03/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | 37.45% | Matthew Harrison60% | $915 → $914 | Maintains | Overweight | Get Alert |
| 11/02/2023 | CERE | Buy Now | Cerevel Therapeutics Hldg | — | — | Matthew Harrison60% | $42 → $38 | Maintains | Overweight | Get Alert |
| 11/02/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 63.52% | Matthew Harrison60% | $125 → $117 | Maintains | Overweight | Get Alert |
| 11/01/2023 | ARGX | Buy Now | argenx | $610.00 | -0.49% | Matthew Harrison60% | $604 → $607 | Maintains | Overweight | Get Alert |
| 10/31/2023 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | 99.67% | Matthew Harrison60% | $183 → $146 | Maintains | Overweight | Get Alert |
| 10/26/2023 | CNTA | Buy Now | Centessa Pharmaceuticals | $16.51 | -51.54% | Matthew Harrison60% | $4 → $8 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 10/11/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | 37.6% | Matthew Harrison60% | $912 → $915 | Maintains | Overweight | Get Alert |
| 10/11/2023 | BIIB | Buy Now | Biogen | $143.09 | 152.29% | Matthew Harrison60% | $381 → $361 | Maintains | Overweight | Get Alert |
| 10/09/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | -29.91% | Matthew Harrison60% | $352 → $359 | Maintains | Equal-Weight | Get Alert |
| 09/25/2023 | VACC | Buy Now | Vaccitech | — | — | Matthew Harrison60% | $14 → $3.25 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 09/05/2023 | BIIB | Buy Now | Biogen | $143.09 | 166.27% | Matthew Harrison60% | $363 → $381 | Maintains | Overweight | Get Alert |
| 08/29/2023 | BGNE | Buy Now | BeiGene | — | — | Matthew Harrison60% | $321 → $319 | Maintains | Overweight | Get Alert |
| 08/18/2023 | VACC | Buy Now | Vaccitech | — | — | Matthew Harrison60% | $15 → $14 | Maintains | Overweight | Get Alert |
| 08/15/2023 | IOBT | Buy Now | IO Biotech | $0.90 | 677% | Matthew Harrison60% | $11 → $7 | Maintains | Overweight | Get Alert |
| 08/15/2023 | PHVS | Buy Now | Pharvaris | $15.96 | 113.03% | Matthew Harrison60% | $10 → $34 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 08/14/2023 | PRME | Buy Now | Prime Medicine | $1.80 | 955.56% | Matthew Harrison60% | $21 → $19 | Maintains | Equal-Weight | Get Alert |
| 08/10/2023 | TNYA | Buy Now | Tenaya Therapeutics | $0.67 | 1981.47% | Matthew Harrison60% | $13 → $14 | Maintains | Overweight | Get Alert |
| 08/07/2023 | ALEC | Buy Now | Alector | $1.32 | 657.58% | Matthew Harrison60% | $10 → $10 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 08/04/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | 37.15% | Matthew Harrison60% | $897 → $912 | Maintains | Overweight | Get Alert |
| 08/04/2023 | MRNA | Buy Now | Moderna | $33.70 | 264.99% | Matthew Harrison60% | $128 → $123 | Maintains | Equal-Weight | Get Alert |
| 08/04/2023 | INSM | Buy Now | Insmed | $76.99 | -46.75% | Matthew Harrison60% | $41 → $41 | Reiterates | Overweight → Overweight | Get Alert |
| 08/04/2023 | GILD | Buy Now | Gilead Sciences | $106.96 | -17.72% | Matthew Harrison60% | $86 → $88 | Maintains | Equal-Weight | Get Alert |
| 08/04/2023 | GMAB | Buy Now | Genmab | $20.20 | 63.37% | Matthew Harrison60% | $33 → $33 | Reiterates | Underweight → Underweight | Get Alert |
| 08/03/2023 | SGEN | Buy Now | Seagen | — | — | Matthew Harrison60% | $229 → $229 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 08/03/2023 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | 150.27% | Matthew Harrison60% | $183 → $183 | Reiterates | Overweight → Overweight | Get Alert |
| 08/03/2023 | CERE | Buy Now | Cerevel Therapeutics Hldg | — | — | Matthew Harrison60% | $46 → $42 | Maintains | Overweight | Get Alert |
| 08/02/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | -31.28% | Matthew Harrison60% | $340 → $352 | Maintains | Equal-Weight | Get Alert |
| 08/01/2023 | PHVS | Buy Now | Pharvaris | $15.96 | -37.34% | Matthew Harrison60% | $10 → $10 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 08/01/2023 | GMAB | Buy Now | Genmab | $20.20 | 63.37% | Matthew Harrison60% | $33 → $33 | Reiterates | Underweight → Underweight | Get Alert |
| 08/01/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 74.7% | Matthew Harrison60% | $129 → $125 | Maintains | Overweight | Get Alert |
| 07/31/2023 | PHVS | Buy Now | Pharvaris | $15.96 | -37.34% | Matthew Harrison60% | $10 → $10 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/31/2023 | GMAB | Buy Now | Genmab | $20.20 | 63.37% | Matthew Harrison60% | $33 → $33 | Reiterates | Underweight → Underweight | Get Alert |
| 07/28/2023 | TSVT | Buy Now | 2seventy bio | $4.96 | 162.1% | Matthew Harrison60% | $25 → $13 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 07/26/2023 | BIIB | Buy Now | Biogen | $143.09 | 153.69% | Matthew Harrison60% | $355 → $363 | Maintains | Overweight | Get Alert |
| 07/24/2023 | PHVS | Buy Now | Pharvaris | $15.96 | -37.34% | Matthew Harrison60% | $10 → $10 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/24/2023 | GMAB | Buy Now | Genmab | $20.20 | 63.37% | Matthew Harrison60% | $33 → $33 | Reiterates | Underweight → Underweight | Get Alert |
| 07/20/2023 | LEGN | Buy Now | Legend Biotech | $38.39 | 121.41% | Matthew Harrison60% | $65 → $85 | Maintains | Overweight | Get Alert |
| 07/20/2023 | ARGX | Buy Now | argenx | $610.00 | -1.31% | Matthew Harrison60% | $452 → $602 | Maintains | Overweight | Get Alert |
| 07/20/2023 | TSVT | Buy Now | 2seventy bio | $4.96 | 404.03% | Matthew Harrison60% | $28 → $25 | Maintains | Overweight | Get Alert |
| 07/17/2023 | PHVS | Buy Now | Pharvaris | $15.96 | -37.34% | Matthew Harrison60% | $10 → $10 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/17/2023 | GMAB | Buy Now | Genmab | $20.20 | 63.37% | Matthew Harrison60% | $33 → $33 | Reiterates | Underweight → Underweight | Get Alert |
| 07/14/2023 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | 150.27% | Matthew Harrison60% | $183 → $183 | Reiterates | Overweight → Overweight | Get Alert |
| 07/11/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | 34.9% | Matthew Harrison60% | $927 → $897 | Maintains | Overweight | Get Alert |
| 07/11/2023 | MRNA | Buy Now | Moderna | $33.70 | 279.82% | Matthew Harrison60% | $153 → $128 | Maintains | Equal-Weight | Get Alert |
| 07/11/2023 | GILD | Buy Now | Gilead Sciences | $106.96 | -19.59% | Matthew Harrison60% | $86 → $86 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/11/2023 | BLUE | Buy Now | bluebird bio | $3.94 | -23.86% | Matthew Harrison60% | $60 → $60 | Reiterates | Underweight → Underweight | Get Alert |
| 07/11/2023 | BIIB | Buy Now | Biogen | $143.09 | 148.1% | Matthew Harrison60% | $371 → $355 | Maintains | Overweight | Get Alert |
| 07/03/2023 | SGTX | Buy Now | Sigilon Therapeutics | — | — | Matthew Harrison60% | $7 → $21 | Maintains | Equal-Weight | Get Alert |
| 06/30/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | -33.62% | Matthew Harrison60% | $305 → $340 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 06/30/2023 | SGTX | Buy Now | Sigilon Therapeutics | — | — | Matthew Harrison60% | $7 → $21 | Maintains | Equal-Weight | Get Alert |
| 06/26/2023 | PHVS | Buy Now | Pharvaris | $15.96 | -37.34% | Matthew Harrison60% | $10 → $10 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 06/26/2023 | GMAB | Buy Now | Genmab | $20.20 | 63.37% | Matthew Harrison60% | $33 → $33 | Reiterates | Underweight → Underweight | Get Alert |
| 06/23/2023 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | 150.27% | Matthew Harrison60% | $183 → $183 | Reiterates | Overweight → Overweight | Get Alert |
| 06/20/2023 | PHVS | Buy Now | Pharvaris | $15.96 | -37.34% | Matthew Harrison60% | → $10 | Reiterates | → Equal-Weight | Get Alert |
| 06/20/2023 | GMAB | Buy Now | Genmab | $20.20 | 63.37% | Matthew Harrison60% | → $33 | Reiterates | → Underweight | Get Alert |
| 06/12/2023 | PHVS | Buy Now | Pharvaris | $15.96 | -37.34% | Matthew Harrison60% | → $10 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 06/12/2023 | GMAB | Buy Now | Genmab | $20.20 | 63.37% | Matthew Harrison60% | → $33 | Reiterates | → Underweight | Get Alert |
| 05/26/2023 | SGTX | Buy Now | Sigilon Therapeutics | — | — | Matthew Harrison60% | $91 → $7 | Maintains | Equal-Weight | Get Alert |
| 05/25/2023 | SGTX | Buy Now | Sigilon Therapeutics | — | — | Matthew Harrison60% | $2 → $91 | Maintains | Equal-Weight | Get Alert |
| 05/16/2023 | VACC | Buy Now | Vaccitech | — | — | Matthew Harrison60% | $16 → $15 | Maintains | Overweight | Get Alert |
| 05/05/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | 39.41% | Matthew Harrison60% | $880 → $927 | Maintains | Overweight | Get Alert |
| 05/05/2023 | MRNA | Buy Now | Moderna | $33.70 | 472.7% | Matthew Harrison60% | $185 → $193 | Maintains | Equal-Weight | Get Alert |
| 05/05/2023 | ARGX | Buy Now | argenx | $610.00 | -25.9% | Matthew Harrison60% | $450 → $452 | Maintains | Overweight | Get Alert |
| 05/02/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | -40.46% | Matthew Harrison60% | $285 → $305 | Maintains | Equal-Weight | Get Alert |
| 05/01/2023 | GILD | Buy Now | Gilead Sciences | $106.96 | -19.59% | Matthew Harrison60% | $85 → $86 | Maintains | Equal-Weight | Get Alert |
| 04/26/2023 | BIIB | Buy Now | Biogen | $143.09 | 159.28% | Matthew Harrison60% | $349 → $371 | Maintains | Overweight | Get Alert |
| 04/24/2023 | CMCSA | Buy Now | Comcast | $36.42 | 26.31% | Matthew Harrison60% | → $46 | Reiterates | → Buy | Get Alert |
| 04/12/2023 | GILD | Buy Now | Gilead Sciences | $106.96 | -20.53% | Matthew Harrison60% | $81 → $85 | Maintains | Equal-Weight | Get Alert |
| 04/12/2023 | DNLI | Buy Now | Denali Therapeutics | $14.51 | 334.18% | Matthew Harrison60% | $61 → $63 | Maintains | Overweight | Get Alert |
| 04/03/2023 | BLUE | Buy Now | bluebird bio | $3.94 | -23.86% | Matthew Harrison60% | $80 → $60 | Maintains | Underweight | Get Alert |
| 03/27/2023 | VIGL | Buy Now | Vigil Neuroscience | $2.07 | 528.02% | Matthew Harrison60% | $12 → $13 | Maintains | Equal-Weight | Get Alert |
| 03/27/2023 | IVVD | Buy Now | Invivyd | $0.84 | 18.91% | Matthew Harrison60% | $2 → $1 | Maintains | Underweight | Get Alert |
| 03/15/2023 | SGEN | Buy Now | Seagen | — | — | Matthew Harrison60% | $173 → $229 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 03/03/2023 | INVA | Buy Now | Innoviva | $17.28 | -42.13% | Matthew Harrison60% | $13 → $10 | Maintains | Underweight | Get Alert |
| 03/03/2023 | ALEC | Buy Now | Alector | $1.32 | 657.58% | Matthew Harrison60% | $11 → $10 | Maintains | Equal-Weight | Get Alert |
| 03/01/2023 | GMAB | Buy Now | Genmab | $20.20 | 63.37% | Matthew Harrison60% | $34 → $33 | Maintains | Underweight | Get Alert |
| 03/01/2023 | DNLI | Buy Now | Denali Therapeutics | $14.51 | 320.4% | Matthew Harrison60% | $65 → $61 | Maintains | Overweight | Get Alert |
| 03/01/2023 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | 155.74% | Matthew Harrison60% | $141 → $187 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 02/28/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 83.09% | Matthew Harrison60% | $132 → $131 | Maintains | Overweight | Get Alert |
| 02/28/2023 | BGNE | Buy Now | BeiGene | — | — | Matthew Harrison60% | $325 → $321 | Maintains | Overweight | Get Alert |
| 02/28/2023 | FULC | Buy Now | Fulcrum Therapeutics | $3.02 | 164.9% | Matthew Harrison60% | $27 → $8 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 02/27/2023 | GLPG | Buy Now | Galapagos | $25.84 | 70.28% | Matthew Harrison60% | $57 → $44 | Maintains | Equal-Weight | Get Alert |
| 02/23/2023 | GMAB | Buy Now | Genmab | $20.20 | 68.32% | Matthew Harrison60% | $35 → $34 | Maintains | Underweight | Get Alert |
| 02/23/2023 | CERE | Buy Now | Cerevel Therapeutics Hldg | — | — | Matthew Harrison60% | $50 → $40 | Maintains | Overweight | Get Alert |
| 02/16/2023 | SGEN | Buy Now | Seagen | — | — | Matthew Harrison60% | $170 → $173 | Maintains | Overweight | Get Alert |
| 02/16/2023 | BIIB | Buy Now | Biogen | $143.09 | 145.3% | Matthew Harrison60% | $345 → $351 | Maintains | Overweight | Get Alert |
| 02/08/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | -44.36% | Matthew Harrison60% | $286 → $285 | Maintains | Equal-Weight | Get Alert |
| 02/06/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | 32.79% | Matthew Harrison60% | $873 → $883 | Maintains | Overweight | Get Alert |
| 02/03/2023 | GILD | Buy Now | Gilead Sciences | $106.96 | -24.27% | Matthew Harrison60% | $80 → $81 | Maintains | Equal-Weight | Get Alert |
| 01/27/2023 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | Matthew Harrison60% | $19 → $10 | Maintains | Overweight | Get Alert |
| 01/25/2023 | DNLI | Buy Now | Denali Therapeutics | $14.51 | 347.97% | Matthew Harrison60% | $60 → $65 | Maintains | Overweight | Get Alert |
| 01/24/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | -44.17% | Matthew Harrison60% | $285 → $286 | Maintains | Equal-Weight | Get Alert |
| 01/24/2023 | TNYA | Buy Now | Tenaya Therapeutics | $0.67 | 1832.8% | Matthew Harrison60% | $15 → $13 | Maintains | Overweight | Get Alert |
| 01/24/2023 | SGEN | Buy Now | Seagen | — | — | Matthew Harrison60% | $171 → $170 | Maintains | Overweight | Get Alert |
| 01/24/2023 | SANA | Buy Now | Sana Biotechnology | $2.33 | 457.94% | Matthew Harrison60% | $15 → $13 | Maintains | Overweight | Get Alert |
| 01/24/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | 31.29% | Matthew Harrison60% | $868 → $873 | Maintains | Overweight | Get Alert |
| 01/24/2023 | PRME | Buy Now | Prime Medicine | $1.80 | 1066.67% | Matthew Harrison60% | $23 → $21 | Maintains | Equal-Weight | Get Alert |
| 01/24/2023 | MRNA | Buy Now | Moderna | $33.70 | 508.31% | Matthew Harrison60% | $209 → $205 | Maintains | Equal-Weight | Get Alert |
| 01/24/2023 | LYEL | Buy Now | Lyell Immunopharma | $0.57 | 607.21% | Matthew Harrison60% | $7 → $4 | Maintains | Equal-Weight | Get Alert |
| 01/24/2023 | LEGN | Buy Now | Legend Biotech | $38.39 | 69.31% | Matthew Harrison60% | $60 → $65 | Maintains | Overweight | Get Alert |
| 01/24/2023 | IOBT | Buy Now | IO Biotech | $0.90 | 1121% | Matthew Harrison60% | $15 → $11 | Maintains | Overweight | Get Alert |
| 01/24/2023 | IVVD | Buy Now | Invivyd | $0.84 | 137.81% | Matthew Harrison60% | $3 → $2 | Maintains | Underweight | Get Alert |
| 01/24/2023 | INVA | Buy Now | Innoviva | $17.28 | -24.77% | Matthew Harrison60% | $14 → $13 | Maintains | Underweight | Get Alert |
| 01/24/2023 | GILD | Buy Now | Gilead Sciences | $106.96 | -25.2% | Matthew Harrison60% | $81 → $80 | Maintains | Equal-Weight | Get Alert |
| 01/24/2023 | GMAB | Buy Now | Genmab | $20.20 | 73.27% | Matthew Harrison60% | $34 → $35 | Maintains | Underweight | Get Alert |
| 01/24/2023 | FULC | Buy Now | Fulcrum Therapeutics | $3.02 | 794.04% | Matthew Harrison60% | $26 → $27 | Maintains | Overweight | Get Alert |
| 01/24/2023 | EDIT | Buy Now | Editas Medicine | $1.35 | 418.52% | Matthew Harrison60% | $8 → $7 | Maintains | Underweight | Get Alert |
| 01/24/2023 | CNTA | Buy Now | Centessa Pharmaceuticals | $16.51 | -75.77% | Matthew Harrison60% | $5 → $4 | Maintains | Underweight | Get Alert |
| 01/24/2023 | BOLT | Buy Now | Bolt Biotherapeutics | $0.40 | 657.58% | Matthew Harrison60% | $5 → $3 | Maintains | Equal-Weight | Get Alert |
| 01/24/2023 | BLUE | Buy Now | bluebird bio | $3.94 | 1.52% | Matthew Harrison60% | $60 → $80 | Maintains | Underweight | Get Alert |
| 01/24/2023 | BNTX | Buy Now | BioNTech | $98.96 | 118.27% | Matthew Harrison60% | $203 → $216 | Maintains | Equal-Weight | Get Alert |
| 01/24/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 84.49% | Matthew Harrison60% | $113 → $132 | Maintains | Overweight | Get Alert |
| 01/24/2023 | BIIB | Buy Now | Biogen | $143.09 | 141.11% | Matthew Harrison60% | $325 → $345 | Maintains | Overweight | Get Alert |
| 01/24/2023 | BGNE | Buy Now | BeiGene | — | — | Matthew Harrison60% | $295 → $325 | Maintains | Overweight | Get Alert |
| 01/24/2023 | AVIR | Buy Now | Atea Pharmaceuticals | $3.17 | 26.18% | Matthew Harrison60% | $7 → $4 | Maintains | Underweight | Get Alert |
| 01/24/2023 | ALEC | Buy Now | Alector | $1.32 | 733.33% | Matthew Harrison60% | $13 → $11 | Maintains | Equal-Weight | Get Alert |
| 01/24/2023 | ADCT | Buy Now | ADC Therapeutics | $1.83 | 173.22% | Matthew Harrison60% | $7 → $5 | Maintains | Equal-Weight | Get Alert |
| 01/24/2023 | ADAG | Buy Now | Adagene | $1.81 | 176.24% | Matthew Harrison60% | $7 → $5 | Maintains | Overweight | Get Alert |
| 01/24/2023 | TSVT | Buy Now | 2seventy bio | $4.96 | 464.52% | Matthew Harrison60% | $29 → $28 | Maintains | Overweight | Get Alert |
| 12/16/2022 | MRNA | Buy Now | Moderna | $33.70 | 520.18% | Matthew Harrison60% | $170 → $209 | Maintains | Equal-Weight | Get Alert |
| 12/06/2022 | ABBV | Buy Now | AbbVie | $214.59 | -15.19% | Matthew Harrison60% | $178 → $182 | Maintains | Overweight | Get Alert |
| 12/01/2022 | GILD | Buy Now | Gilead Sciences | $106.96 | -24.27% | Matthew Harrison60% | $68 → $81 | Maintains | Equal-Weight | Get Alert |
| 11/18/2022 | EDIT | Buy Now | Editas Medicine | $1.35 | 492.59% | Matthew Harrison60% | $10 → $8 | Maintains | Underweight | Get Alert |
| 11/14/2022 | VIGL | Buy Now | Vigil Neuroscience | $2.07 | 479.71% | Matthew Harrison60% | $11 → $12 | Maintains | Equal-Weight | Get Alert |
| 11/14/2022 | KOD | Buy Now | Kodiak Sciences | $3.24 | 177.78% | Matthew Harrison60% | $12 → $9 | Maintains | Equal-Weight | Get Alert |
| 11/14/2022 | GMAB | Buy Now | Genmab | $20.20 | 68.32% | Matthew Harrison60% | $31 → $34 | Maintains | Underweight | Get Alert |
| 11/14/2022 | FULC | Buy Now | Fulcrum Therapeutics | $3.02 | 760.93% | Matthew Harrison60% | $25 → $26 | Maintains | Overweight | Get Alert |
| 11/14/2022 | ADCT | Buy Now | ADC Therapeutics | $1.83 | 282.51% | Matthew Harrison60% | $11 → $7 | Maintains | Equal-Weight | Get Alert |
| 11/14/2022 | PRME | Buy Now | Prime Medicine | $1.80 | 1177.78% | Matthew Harrison60% | → $23 | Initiates | → Equal-Weight | Get Alert |
| 11/14/2022 | LYEL | Buy Now | Lyell Immunopharma | $0.57 | 1137.62% | Matthew Harrison60% | $15 → $7 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/11/2022 | ZNTL | Buy Now | Zentalis Pharma | $1.79 | 2972.63% | Matthew Harrison60% | $60 → $55 | Maintains | Overweight | Get Alert |
| 11/08/2022 | EDIT | Buy Now | Editas Medicine | $1.35 | 640.74% | Matthew Harrison60% | $15 → $10 | Maintains | Underweight | Get Alert |
| 11/08/2022 | DNLI | Buy Now | Denali Therapeutics | $14.51 | 313.51% | Matthew Harrison60% | $67 → $60 | Maintains | Overweight | Get Alert |
| 11/08/2022 | BNTX | Buy Now | BioNTech | $98.96 | 105.13% | Matthew Harrison60% | $194 → $203 | Maintains | Equal-Weight | Get Alert |
| 11/08/2022 | TSVT | Buy Now | 2seventy bio | $4.96 | 484.68% | Matthew Harrison60% | $27 → $29 | Maintains | Overweight | Get Alert |
| 11/07/2022 | GLPG | Buy Now | Galapagos | $25.84 | 120.59% | Matthew Harrison60% | $63 → $57 | Maintains | Equal-Weight | Get Alert |
| 11/07/2022 | AKRO | Buy Now | Akero Therapeutics | $43.53 | -8.11% | Matthew Harrison60% | $30 → $40 | Maintains | Equal-Weight | Get Alert |
| 11/04/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | 30.53% | Matthew Harrison60% | $851 → $868 | Maintains | Overweight | Get Alert |
| 11/04/2022 | MRNA | Buy Now | Moderna | $33.70 | 404.45% | Matthew Harrison60% | $175 → $170 | Maintains | Equal-Weight | Get Alert |
| 11/04/2022 | AMGN | Buy Now | Amgen | $319.93 | -11.85% | Matthew Harrison60% | $279 → $282 | Maintains | Overweight | Get Alert |
| 10/31/2022 | ABBV | Buy Now | AbbVie | $214.59 | -17.05% | Matthew Harrison60% | $185 → $178 | Maintains | Overweight | Get Alert |
| 10/28/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | -44.36% | Matthew Harrison60% | $253 → $285 | Maintains | Equal-Weight | Get Alert |
| 10/28/2022 | SGEN | Buy Now | Seagen | — | — | Matthew Harrison60% | $170 → $171 | Maintains | Overweight | Get Alert |
| 10/28/2022 | GILD | Buy Now | Gilead Sciences | $106.96 | -36.42% | Matthew Harrison60% | $67 → $68 | Maintains | Equal-Weight | Get Alert |
| 10/28/2022 | ARGX | Buy Now | argenx | $610.00 | -26.23% | Matthew Harrison60% | $401 → $450 | Maintains | Overweight | Get Alert |
| 10/28/2022 | ALNY | Buy Now | Alnylam Pharmaceuticals | $244.30 | -14.04% | Matthew Harrison60% | $220 → $210 | Maintains | Equal-Weight | Get Alert |
| 10/27/2022 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 57.93% | Matthew Harrison60% | $111 → $113 | Maintains | Overweight | Get Alert |
| 10/26/2022 | BIIB | Buy Now | Biogen | $143.09 | 127.13% | Matthew Harrison60% | $321 → $325 | Maintains | Overweight | Get Alert |
| 10/18/2022 | MRNA | Buy Now | Moderna | $33.70 | 419.29% | Matthew Harrison60% | $197 → $175 | Maintains | Equal-Weight | Get Alert |
| 10/13/2022 | SGEN | Buy Now | Seagen | — | — | Matthew Harrison60% | $181 → $170 | Maintains | Overweight | Get Alert |
| 10/13/2022 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | 92.83% | Matthew Harrison60% | $135 → $141 | Maintains | Equal-Weight | Get Alert |
| 10/13/2022 | LEGN | Buy Now | Legend Biotech | $38.39 | 56.29% | Matthew Harrison60% | $63 → $60 | Maintains | Overweight | Get Alert |
| 10/13/2022 | INVA | Buy Now | Innoviva | $17.28 | -18.98% | Matthew Harrison60% | $13 → $14 | Maintains | Underweight | Get Alert |
| 10/13/2022 | GILD | Buy Now | Gilead Sciences | $106.96 | -37.36% | Matthew Harrison60% | $65 → $67 | Maintains | Equal-Weight | Get Alert |
| 10/13/2022 | GLPG | Buy Now | Galapagos | $25.84 | 143.81% | Matthew Harrison60% | $61 → $63 | Maintains | Equal-Weight | Get Alert |
| 10/13/2022 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 55.14% | Matthew Harrison60% | $117 → $111 | Maintains | Overweight | Get Alert |
| 10/13/2022 | BIIB | Buy Now | Biogen | $143.09 | 124.33% | Matthew Harrison60% | $285 → $321 | Maintains | Overweight | Get Alert |
| 10/13/2022 | BGNE | Buy Now | BeiGene | — | — | Matthew Harrison60% | $290 → $295 | Maintains | Overweight | Get Alert |
| 10/13/2022 | ALNY | Buy Now | Alnylam Pharmaceuticals | $244.30 | -9.95% | Matthew Harrison60% | $222 → $220 | Maintains | Equal-Weight | Get Alert |
| 10/11/2022 | ABBV | Buy Now | AbbVie | $214.59 | -13.79% | Matthew Harrison60% | $188 → $185 | Maintains | Overweight | Get Alert |
| 10/11/2022 | AMGN | Buy Now | Amgen | $319.93 | -12.79% | Matthew Harrison60% | $257 → $279 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 09/14/2022 | IVVD | Buy Now | Invivyd | $0.84 | 256.72% | Matthew Harrison60% | → $3 | Maintains | Underweight | Get Alert |
| 09/14/2022 | AKRO | Buy Now | Akero Therapeutics | $43.53 | -31.08% | Matthew Harrison60% | $26 → $30 | Maintains | Equal-Weight | Get Alert |
| 09/09/2022 | ALNY | Buy Now | Alnylam Pharmaceuticals | $244.30 | -9.13% | Matthew Harrison60% | $225 → $222 | Maintains | Equal-Weight | Get Alert |
| 09/09/2022 | ALVR | Buy Now | AlloVir | $9.67 | 179.21% | Matthew Harrison60% | $736 → $621 | Maintains | Overweight | Get Alert |
| 09/09/2022 | ADAG | Buy Now | Adagene | $1.81 | 286.74% | Matthew Harrison60% | $15 → $7 | Maintains | Overweight | Get Alert |
| 09/09/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | 27.98% | Matthew Harrison60% | $625 → $851 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 09/09/2022 | GLPG | Buy Now | Galapagos | $25.84 | 136.07% | Matthew Harrison60% | $80 → $61 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 09/09/2022 | ALEC | Buy Now | Alector | $1.32 | 884.85% | Matthew Harrison60% | $27 → $13 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 09/09/2022 | ADCT | Buy Now | ADC Therapeutics | $1.83 | 501.09% | Matthew Harrison60% | $17 → $11 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 09/08/2022 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | 84.63% | Matthew Harrison60% | $100 → $135 | Maintains | Equal-Weight | Get Alert |
| 08/23/2022 | PHVS | Buy Now | Pharvaris | $15.96 | -37.34% | Matthew Harrison60% | $40 → $10 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 08/22/2022 | CERE | Buy Now | Cerevel Therapeutics Hldg | — | — | Matthew Harrison60% | $39 → $50 | Maintains | Overweight | Get Alert |
| 08/15/2022 | VACC | Buy Now | Vaccitech | — | — | Matthew Harrison60% | $19 → $16 | Maintains | Overweight | Get Alert |
| 08/15/2022 | KOD | Buy Now | Kodiak Sciences | $3.24 | 270.37% | Matthew Harrison60% | $10 → $12 | Maintains | Equal-Weight | Get Alert |
| 08/15/2022 | GMAB | Buy Now | Genmab | $20.20 | 53.47% | Matthew Harrison60% | $29 → $31 | Maintains | Underweight | Get Alert |
| 08/15/2022 | GLPG | Buy Now | Galapagos | $25.84 | 209.6% | Matthew Harrison60% | $79 → $80 | Maintains | Overweight | Get Alert |
| 08/15/2022 | AVIR | Buy Now | Atea Pharmaceuticals | $3.17 | 120.82% | Matthew Harrison60% | $6 → $7 | Maintains | Underweight | Get Alert |
| 08/15/2022 | TSVT | Buy Now | 2seventy bio | $4.96 | 444.35% | Matthew Harrison60% | $28 → $27 | Maintains | Overweight | Get Alert |
| 08/12/2022 | CNTA | Buy Now | Centessa Pharmaceuticals | $16.51 | -69.72% | Matthew Harrison60% | $10 → $5 | Downgrade | Overweight → Underweight | Get Alert |
| 08/11/2022 | ZNTL | Buy Now | Zentalis Pharma | $1.79 | 3251.96% | Matthew Harrison60% | $95 → $60 | Maintains | Overweight | Get Alert |
| 08/08/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | -50.61% | Matthew Harrison60% | $250 → $253 | Maintains | Equal-Weight | Get Alert |
| 08/08/2022 | INVA | Buy Now | Innoviva | $17.28 | -24.77% | Matthew Harrison60% | $12 → $13 | Maintains | Underweight | Get Alert |
| 08/04/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -6.01% | Matthew Harrison60% | $619 → $625 | Maintains | Equal-Weight | Get Alert |
| 08/04/2022 | MRNA | Buy Now | Moderna | $33.70 | 484.57% | Matthew Harrison60% | $199 → $197 | Maintains | Equal-Weight | Get Alert |
| 08/04/2022 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 63.52% | Matthew Harrison60% | $113 → $117 | Maintains | Overweight | Get Alert |
| 08/04/2022 | ALNY | Buy Now | Alnylam Pharmaceuticals | $244.30 | -7.9% | Matthew Harrison60% | $159 → $225 | Maintains | Equal-Weight | Get Alert |
| 08/03/2022 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | 36.76% | Matthew Harrison60% | $80 → $100 | Maintains | Equal-Weight | Get Alert |
| 08/01/2022 | ABBV | Buy Now | AbbVie | $214.59 | -12.39% | Matthew Harrison60% | $191 → $188 | Maintains | Overweight | Get Alert |
| 07/29/2022 | SGEN | Buy Now | Seagen | — | — | Matthew Harrison60% | $180 → $181 | Maintains | Overweight | Get Alert |
| 07/29/2022 | ARGX | Buy Now | argenx | $610.00 | -34.26% | Matthew Harrison60% | $375 → $401 | Maintains | Overweight | Get Alert |
| 07/29/2022 | ALNY | Buy Now | Alnylam Pharmaceuticals | $244.30 | -34.92% | Matthew Harrison60% | $164 → $159 | Maintains | Equal-Weight | Get Alert |
| 07/15/2022 | SGEN | Buy Now | Seagen | — | — | Matthew Harrison60% | $173 → $180 | Maintains | Overweight | Get Alert |
| 07/15/2022 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | 9.41% | Matthew Harrison60% | $74 → $80 | Maintains | Equal-Weight | Get Alert |
| 07/15/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -6.91% | Matthew Harrison60% | $610 → $619 | Maintains | Equal-Weight | Get Alert |
| 07/15/2022 | LEGN | Buy Now | Legend Biotech | $38.39 | 64.1% | Matthew Harrison60% | $55 → $63 | Maintains | Overweight | Get Alert |
| 07/15/2022 | INSM | Buy Now | Insmed | $76.99 | -46.75% | Matthew Harrison60% | $46 → $41 | Maintains | Overweight | Get Alert |
| 07/15/2022 | INVA | Buy Now | Innoviva | $17.28 | -30.56% | Matthew Harrison60% | $13 → $12 | Maintains | Underweight | Get Alert |
| 07/15/2022 | GILD | Buy Now | Gilead Sciences | $106.96 | -39.23% | Matthew Harrison60% | $63 → $65 | Maintains | Equal-Weight | Get Alert |
| 07/15/2022 | GLPG | Buy Now | Galapagos | $25.84 | 205.73% | Matthew Harrison60% | $80 → $79 | Maintains | Overweight | Get Alert |
| 07/15/2022 | CNTA | Buy Now | Centessa Pharmaceuticals | $16.51 | -39.43% | Matthew Harrison60% | $15 → $10 | Maintains | Overweight | Get Alert |
| 07/15/2022 | BNTX | Buy Now | BioNTech | $98.96 | 96.04% | Matthew Harrison60% | $195 → $194 | Maintains | Equal-Weight | Get Alert |
| 07/15/2022 | BGNE | Buy Now | BeiGene | — | — | Matthew Harrison60% | $300 → $293 | Maintains | Overweight | Get Alert |
| 07/15/2022 | AMGN | Buy Now | Amgen | $319.93 | -20.92% | Matthew Harrison60% | $239 → $253 | Maintains | Equal-Weight | Get Alert |
| 07/15/2022 | TSVT | Buy Now | 2seventy bio | $4.96 | 464.52% | Matthew Harrison60% | $31 → $28 | Maintains | Overweight | Get Alert |
| 06/03/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -8.27% | Matthew Harrison60% | $620 → $610 | Maintains | Equal-Weight | Get Alert |
| 05/24/2022 | CNTA | Buy Now | Centessa Pharmaceuticals | $16.51 | -9.15% | Matthew Harrison60% | $19 → $15 | Maintains | Overweight | Get Alert |
| 05/19/2022 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | 1.2% | Matthew Harrison60% | $77 → $74 | Maintains | Equal-Weight | Get Alert |
| 05/17/2022 | VIGL | Buy Now | Vigil Neuroscience | $2.07 | 431.4% | Matthew Harrison60% | $17 → $11 | Maintains | Equal-Weight | Get Alert |
| 05/17/2022 | VACC | Buy Now | Vaccitech | — | — | Matthew Harrison60% | $20 → $19 | Maintains | Overweight | Get Alert |
| 05/17/2022 | TNYA | Buy Now | Tenaya Therapeutics | $0.67 | 2130.15% | Matthew Harrison60% | $19 → $15 | Maintains | Overweight | Get Alert |
| 05/17/2022 | SANA | Buy Now | Sana Biotechnology | $2.33 | 543.78% | Matthew Harrison60% | $17 → $15 | Maintains | Overweight | Get Alert |
| 05/17/2022 | KOD | Buy Now | Kodiak Sciences | $3.24 | 208.64% | Matthew Harrison60% | $12 → $10 | Maintains | Equal-Weight | Get Alert |
| 05/17/2022 | GMAB | Buy Now | Genmab | $20.20 | 43.56% | Matthew Harrison60% | $30 → $29 | Maintains | Underweight | Get Alert |
| 05/17/2022 | FULC | Buy Now | Fulcrum Therapeutics | $3.02 | 727.81% | Matthew Harrison60% | $26 → $25 | Maintains | Overweight | Get Alert |
| 05/17/2022 | BOLT | Buy Now | Bolt Biotherapeutics | $0.40 | 1162.63% | Matthew Harrison60% | $7 → $5 | Maintains | Equal-Weight | Get Alert |
| 05/17/2022 | BLUE | Buy Now | bluebird bio | $3.94 | -23.86% | Matthew Harrison60% | $100 → $60 | Maintains | Underweight | Get Alert |
| 05/17/2022 | ADGI | Buy Now | Adagio Therapeutics | — | — | Matthew Harrison60% | $6 → $3 | Maintains | Underweight | Get Alert |
| 05/17/2022 | TSVT | Buy Now | 2seventy bio | $4.96 | 525% | Matthew Harrison60% | $36 → $31 | Maintains | Overweight | Get Alert |
| 05/10/2022 | BNTX | Buy Now | BioNTech | $98.96 | 97.05% | Matthew Harrison60% | $197 → $195 | Maintains | Equal-Weight | Get Alert |
| 05/10/2022 | ADCT | Buy Now | ADC Therapeutics | $1.83 | 828.96% | Matthew Harrison60% | $30 → $17 | Maintains | Overweight | Get Alert |
| 05/09/2022 | EDIT | Buy Now | Editas Medicine | $1.35 | 1011.11% | Matthew Harrison60% | $17 → $15 | Maintains | Underweight | Get Alert |
| 05/09/2022 | BGNE | Buy Now | BeiGene | — | — | Matthew Harrison60% | $338 → $300 | Maintains | Overweight | Get Alert |
| 05/05/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -6.76% | Matthew Harrison60% | $632 → $620 | Maintains | Equal-Weight | Get Alert |
| 05/05/2022 | MRNA | Buy Now | Moderna | $33.70 | 490.5% | Matthew Harrison60% | $217 → $199 | Maintains | Equal-Weight | Get Alert |
| 05/04/2022 | PFE | Buy Now | Pfizer | $26.30 | 97.71% | Matthew Harrison60% | $55 → $52 | Maintains | Equal-Weight | Get Alert |
| 05/04/2022 | BIIB | Buy Now | Biogen | $143.09 | 99.18% | Matthew Harrison60% | $283 → $285 | Maintains | Overweight | Get Alert |
| 05/03/2022 | ARGX | Buy Now | argenx | $610.00 | -38.52% | Matthew Harrison60% | → $375 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 05/03/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | -51.19% | Matthew Harrison60% | → $250 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 05/02/2022 | ABBV | Buy Now | AbbVie | $214.59 | -12.39% | Matthew Harrison60% | $192 → $188 | Maintains | Overweight | Get Alert |
| 04/29/2022 | ALNY | Buy Now | Alnylam Pharmaceuticals | $244.30 | -30.41% | Matthew Harrison60% | $178 → $170 | Maintains | Equal-Weight | Get Alert |
| 04/25/2022 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 57.93% | Matthew Harrison60% | $96 → $113 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 04/25/2022 | ALNY | Buy Now | Alnylam Pharmaceuticals | $244.30 | -27.14% | Matthew Harrison60% | $210 → $178 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 04/12/2022 | SGEN | Buy Now | Seagen | — | — | Matthew Harrison60% | $170 → $173 | Maintains | Overweight | Get Alert |
| 04/12/2022 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | 5.31% | Matthew Harrison60% | $80 → $77 | Maintains | Equal-Weight | Get Alert |
| 04/12/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -4.96% | Matthew Harrison60% | $605 → $632 | Maintains | Equal-Weight | Get Alert |
| 04/12/2022 | MRNA | Buy Now | Moderna | $33.70 | 543.92% | Matthew Harrison60% | $205 → $217 | Maintains | Equal-Weight | Get Alert |
| 04/12/2022 | KOD | Buy Now | Kodiak Sciences | $3.24 | 270.37% | Matthew Harrison60% | $17 → $12 | Maintains | Equal-Weight | Get Alert |
| 04/12/2022 | INVA | Buy Now | Innoviva | $17.28 | -24.77% | Matthew Harrison60% | $12 → $13 | Maintains | Underweight | Get Alert |
| 04/12/2022 | GILD | Buy Now | Gilead Sciences | $106.96 | -41.1% | Matthew Harrison60% | $69 → $63 | Maintains | Equal-Weight | Get Alert |
| 04/12/2022 | GMAB | Buy Now | Genmab | $20.20 | 48.51% | Matthew Harrison60% | $33 → $30 | Maintains | Underweight | Get Alert |
| 04/12/2022 | FULC | Buy Now | Fulcrum Therapeutics | $3.02 | 760.93% | Matthew Harrison60% | $25 → $26 | Maintains | Overweight | Get Alert |
| 04/12/2022 | EDIT | Buy Now | Editas Medicine | $1.35 | 1159.26% | Matthew Harrison60% | $16 → $17 | Maintains | Underweight | Get Alert |
| 04/12/2022 | BNTX | Buy Now | BioNTech | $98.96 | 99.07% | Matthew Harrison60% | $217 → $197 | Maintains | Equal-Weight | Get Alert |
| 04/12/2022 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 34.17% | Matthew Harrison60% | $90 → $96 | Maintains | Equal-Weight | Get Alert |
| 04/12/2022 | BIIB | Buy Now | Biogen | $143.09 | 97.78% | Matthew Harrison60% | $330 → $283 | Maintains | Overweight | Get Alert |
| 04/12/2022 | BGNE | Buy Now | BeiGene | — | — | Matthew Harrison60% | $330 → $338 | Maintains | Overweight | Get Alert |
| 04/12/2022 | AMGN | Buy Now | Amgen | $319.93 | -25.92% | Matthew Harrison60% | $238 → $237 | Maintains | Equal-Weight | Get Alert |
| 04/12/2022 | ADCT | Buy Now | ADC Therapeutics | $1.83 | 1539.34% | Matthew Harrison60% | $29 → $30 | Maintains | Overweight | Get Alert |
| 04/06/2022 | JNJ | Buy Now | Johnson & Johnson | $164.25 | 5.33% | Matthew Harrison60% | $175 → $173 | Maintains | Equal-Weight | Get Alert |
| 04/05/2022 | CNTA | Buy Now | Centessa Pharmaceuticals | $16.51 | 15.08% | Matthew Harrison60% | $20 → $19 | Maintains | Overweight | Get Alert |
| 03/10/2022 | SAGE | Buy Now | Sage Therapeutics | $7.84 | 627.04% | Matthew Harrison60% | $61 → $57 | Maintains | Equal-Weight | Get Alert |
| 03/07/2022 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | 9.41% | Matthew Harrison60% | $71 → $80 | Maintains | Equal-Weight | Get Alert |
| 03/07/2022 | LEGN | Buy Now | Legend Biotech | $38.39 | 43.26% | Matthew Harrison60% | $51 → $55 | Maintains | Overweight | Get Alert |
| 03/07/2022 | BLUE | Buy Now | bluebird bio | $3.94 | 26.9% | Matthew Harrison60% | $120 → $100 | Maintains | Underweight | Get Alert |
| 03/07/2022 | ARGX | Buy Now | argenx | $610.00 | -54.43% | Matthew Harrison60% | $274 → $278 | Maintains | Equal-Weight | Get Alert |
| 02/28/2022 | MRNA | Buy Now | Moderna | $33.70 | 508.31% | Matthew Harrison60% | $213 → $205 | Maintains | Equal-Weight | Get Alert |
| 02/28/2022 | GBT | Buy Now | Global Blood Therapeutics | — | — | Matthew Harrison60% | $28 → $31 | Maintains | Equal-Weight | Get Alert |
| 02/28/2022 | GLPG | Buy Now | Galapagos | $25.84 | 209.6% | Matthew Harrison60% | $77 → $80 | Maintains | Overweight | Get Alert |
| 02/28/2022 | BGNE | Buy Now | BeiGene | — | — | Matthew Harrison60% | $360 → $330 | Maintains | Overweight | Get Alert |
| 02/24/2022 | KOD | Buy Now | Kodiak Sciences | $3.24 | 424.69% | Matthew Harrison60% | $77 → $17 | Maintains | Equal-Weight | Get Alert |
| 02/23/2022 | INVA | Buy Now | Innoviva | $17.28 | -30.56% | Matthew Harrison60% | $10 → $12 | Maintains | Underweight | Get Alert |
| 02/10/2022 | SGEN | Buy Now | Seagen | — | — | Matthew Harrison60% | $175 → $170 | Maintains | Overweight | Get Alert |
| 02/10/2022 | PFE | Buy Now | Pfizer | $26.30 | 109.12% | Matthew Harrison60% | $60 → $55 | Maintains | Equal-Weight | Get Alert |
| 02/09/2022 | AMGN | Buy Now | Amgen | $319.93 | -25.61% | Matthew Harrison60% | $235 → $238 | Maintains | Equal-Weight | Get Alert |
| 02/07/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -9.02% | Matthew Harrison60% | $585 → $605 | Maintains | Equal-Weight | Get Alert |
| 02/04/2022 | BIIB | Buy Now | Biogen | $143.09 | 130.62% | Matthew Harrison60% | $360 → $330 | Maintains | Overweight | Get Alert |
| 02/02/2022 | GILD | Buy Now | Gilead Sciences | $106.96 | -35.49% | Matthew Harrison60% | $72 → $69 | Maintains | Equal-Weight | Get Alert |
| 02/01/2022 | ADAG | Buy Now | Adagene | $1.81 | 728.73% | Matthew Harrison60% | $27 → $15 | Maintains | Overweight | Get Alert |
| 02/01/2022 | ADCT | Buy Now | ADC Therapeutics | $1.83 | 1484.7% | Matthew Harrison60% | $47 → $29 | Maintains | Overweight | Get Alert |
| 02/01/2022 | KOD | Buy Now | Kodiak Sciences | $3.24 | 2276.54% | Matthew Harrison60% | $122 → $77 | Maintains | Equal-Weight | Get Alert |
| 02/01/2022 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | -2.9% | Matthew Harrison60% | $92 → $71 | Maintains | Equal-Weight | Get Alert |
| 02/01/2022 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.86 | 208.8% | Matthew Harrison60% | $156 → $120 | Maintains | Overweight | Get Alert |
| 02/01/2022 | MRNA | Buy Now | Moderna | $33.70 | 532.05% | Matthew Harrison60% | $315 → $213 | Maintains | Equal-Weight | Get Alert |
| 02/01/2022 | BNTX | Buy Now | BioNTech | $98.96 | 119.28% | Matthew Harrison60% | $284 → $217 | Maintains | Equal-Weight | Get Alert |
| 02/01/2022 | ARGX | Buy Now | argenx | $610.00 | -55.08% | Matthew Harrison60% | $339 → $274 | Maintains | Equal-Weight | Get Alert |
| 02/01/2022 | VIGL | Buy Now | Vigil Neuroscience | $2.07 | 721.26% | Matthew Harrison60% | → $17 | Initiates | → Equal-Weight | Get Alert |
| 01/31/2022 | LEGN | Buy Now | Legend Biotech | $38.39 | 32.84% | Matthew Harrison60% | → $51 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 01/31/2022 | SGEN | Buy Now | Seagen | — | — | Matthew Harrison60% | → $175 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 01/24/2022 | JNJ | Buy Now | Johnson & Johnson | $164.25 | 6.54% | Matthew Harrison60% | $187 → $175 | Maintains | Equal-Weight | Get Alert |
| 01/24/2022 | ABBV | Buy Now | AbbVie | $214.59 | -33.83% | Matthew Harrison60% | $124 → $142 | Maintains | Overweight | Get Alert |
| 01/18/2022 | SGEN | Buy Now | Seagen | — | — | Matthew Harrison60% | $181 → $178 | Maintains | Equal-Weight | Get Alert |
| 01/18/2022 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | 25.82% | Matthew Harrison60% | $90 → $92 | Maintains | Equal-Weight | Get Alert |
| 01/18/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -12.02% | Matthew Harrison60% | $617 → $585 | Maintains | Equal-Weight | Get Alert |
| 01/18/2022 | MRNA | Buy Now | Moderna | $33.70 | 834.72% | Matthew Harrison60% | $313 → $315 | Maintains | Equal-Weight | Get Alert |
| 01/18/2022 | KOD | Buy Now | Kodiak Sciences | $3.24 | 3665.43% | Matthew Harrison60% | $119 → $122 | Maintains | Equal-Weight | Get Alert |
| 01/18/2022 | GILD | Buy Now | Gilead Sciences | $106.96 | -32.68% | Matthew Harrison60% | $74 → $72 | Maintains | Equal-Weight | Get Alert |
| 01/18/2022 | BNTX | Buy Now | BioNTech | $98.96 | 186.98% | Matthew Harrison60% | $294 → $284 | Maintains | Equal-Weight | Get Alert |
| 01/18/2022 | BIIB | Buy Now | Biogen | $143.09 | 151.59% | Matthew Harrison60% | $363 → $360 | Maintains | Overweight | Get Alert |
| 01/18/2022 | BGNE | Buy Now | BeiGene | — | — | Matthew Harrison60% | $407 → $360 | Maintains | Overweight | Get Alert |
| 01/18/2022 | ARGX | Buy Now | argenx | $610.00 | -44.43% | Matthew Harrison60% | $351 → $339 | Maintains | Equal-Weight | Get Alert |
| 01/18/2022 | ALVR | Buy Now | AlloVir | $9.67 | 365.36% | Matthew Harrison60% | $1104 → $1035 | Maintains | Overweight | Get Alert |
| 01/07/2022 | BHVN | Buy Now | Biohaven | $28.51 | 419.12% | Matthew Harrison60% | $145 → $148 | Maintains | Equal-Weight | Get Alert |
| 01/06/2022 | LYEL | Buy Now | Lyell Immunopharma | $0.57 | 3436.07% | Matthew Harrison60% | $25 → $20 | Maintains | Overweight | Get Alert |
| 01/06/2022 | IMRA | Buy Now | Imara | — | — | Matthew Harrison60% | $48 → $16 | Maintains | Equal-Weight | Get Alert |
| 01/06/2022 | GLPG | Buy Now | Galapagos | $25.84 | 197.99% | Matthew Harrison60% | $118 → $77 | Maintains | Overweight | Get Alert |
| 01/06/2022 | EDIT | Buy Now | Editas Medicine | $1.35 | 1677.78% | Matthew Harrison60% | $37 → $24 | Maintains | Underweight | Get Alert |
| 01/06/2022 | DNLI | Buy Now | Denali Therapeutics | $14.51 | 527.15% | Matthew Harrison60% | $99 → $91 | Maintains | Overweight | Get Alert |
| 01/06/2022 | BLUE | Buy Now | bluebird bio | $3.94 | 153.81% | Matthew Harrison60% | $220 → $200 | Maintains | Underweight | Get Alert |
| 01/06/2022 | BIIB | Buy Now | Biogen | $143.09 | 153.69% | Matthew Harrison60% | $440 → $363 | Maintains | Overweight | Get Alert |
| 01/06/2022 | ADAG | Buy Now | Adagene | $1.81 | 1391.71% | Matthew Harrison60% | $33 → $27 | Maintains | Overweight | Get Alert |
| 01/06/2022 | LEGN | Buy Now | Legend Biotech | $38.39 | — | Matthew Harrison60% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 01/06/2022 | BOLT | Buy Now | Bolt Biotherapeutics | $0.40 | 2677.78% | Matthew Harrison60% | $45 → $11 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 01/06/2022 | AVIR | Buy Now | Atea Pharmaceuticals | $3.17 | 120.82% | Matthew Harrison60% | $14 → $7 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 01/06/2022 | ADGI | Buy Now | Adagio Therapeutics | — | — | Matthew Harrison60% | $11 → $6 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 01/06/2022 | GILD | Buy Now | Gilead Sciences | $106.96 | -30.81% | Matthew Harrison60% | $84 → $74 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/16/2021 | BNTX | Buy Now | BioNTech | $98.96 | 197.09% | Matthew Harrison60% | → $294 | Initiates | → Equal-Weight | Get Alert |
| 12/15/2021 | ADGI | Buy Now | Adagio Therapeutics | — | — | Matthew Harrison60% | $49 → $11 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/30/2021 | SGTX | Buy Now | Sigilon Therapeutics | — | — | Matthew Harrison60% | $117 → $58.5 | Maintains | Equal-Weight | Get Alert |
| 11/30/2021 | IOBT | Buy Now | IO Biotech | $0.90 | 2231% | Matthew Harrison60% | → $21 | Initiates | → Overweight | Get Alert |
| 11/29/2021 | PFE | Buy Now | Pfizer | $26.30 | 128.13% | Matthew Harrison60% | $50 → $60 | Maintains | Equal-Weight | Get Alert |
| 11/29/2021 | MRK | Buy Now | Merck & Co | $94.90 | -13.59% | Matthew Harrison60% | $88 → $82 | Maintains | Equal-Weight | Get Alert |
| 11/29/2021 | ADGI | Buy Now | Adagio Therapeutics | — | — | Matthew Harrison60% | → $49 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 11/22/2021 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 25.79% | Matthew Harrison60% | $82 → $90 | Maintains | Equal-Weight | Get Alert |
| 11/15/2021 | AKRO | Buy Now | Akero Therapeutics | $43.53 | -33.38% | Matthew Harrison60% | $27 → $29 | Maintains | Equal-Weight | Get Alert |
| 11/08/2021 | TSVT | Buy Now | 2seventy bio | $4.96 | 1351.61% | Matthew Harrison60% | → $72 | Initiates | → Overweight | Get Alert |
| 11/08/2021 | BLUE | Buy Now | bluebird bio | $3.94 | 179.19% | Matthew Harrison60% | → $220 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 11/05/2021 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -7.21% | Matthew Harrison60% | $571 → $617 | Maintains | Equal-Weight | Get Alert |
| 11/05/2021 | MRNA | Buy Now | Moderna | $33.70 | 828.78% | Matthew Harrison60% | $337 → $313 | Maintains | Equal-Weight | Get Alert |
| 11/01/2021 | ABBV | Buy Now | AbbVie | $214.59 | -42.22% | Matthew Harrison60% | $116 → $124 | Maintains | Overweight | Get Alert |
| 10/29/2021 | SGEN | Buy Now | Seagen | — | — | Matthew Harrison60% | $167 → $181 | Maintains | Equal-Weight | Get Alert |
| 10/29/2021 | MRK | Buy Now | Merck & Co | $94.90 | -5.16% | Matthew Harrison60% | $88 → $90 | Maintains | Equal-Weight | Get Alert |
| 10/21/2021 | BIIB | Buy Now | Biogen | $143.09 | 207.5% | Matthew Harrison60% | $447 → $440 | Maintains | Overweight | Get Alert |
| 10/19/2021 | BHVN | Buy Now | Biohaven | $28.51 | 408.59% | Matthew Harrison60% | $107 → $145 | Maintains | Equal-Weight | Get Alert |
| 10/19/2021 | KLDO | Buy Now | Kaleido Biosciences | $0.00 | 2999900% | Matthew Harrison60% | → $3 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 10/19/2021 | AKRO | Buy Now | Akero Therapeutics | $43.53 | -37.97% | Matthew Harrison60% | → $27 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 10/12/2021 | SAGE | Buy Now | Sage Therapeutics | $7.84 | 894.9% | Matthew Harrison60% | $81 → $78 | Maintains | Equal-Weight | Get Alert |
| 10/12/2021 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -14.13% | Matthew Harrison60% | $606 → $571 | Maintains | Equal-Weight | Get Alert |
| 10/12/2021 | PFE | Buy Now | Pfizer | $26.30 | 82.5% | Matthew Harrison60% | $45 → $48 | Maintains | Equal-Weight | Get Alert |
| 10/12/2021 | MRK | Buy Now | Merck & Co | $94.90 | -7.27% | Matthew Harrison60% | $85 → $88 | Maintains | Equal-Weight | Get Alert |
| 10/12/2021 | LEGN | Buy Now | Legend Biotech | $38.39 | 32.84% | Matthew Harrison60% | $50 → $51 | Maintains | Overweight | Get Alert |
| 10/12/2021 | GILD | Buy Now | Gilead Sciences | $106.96 | -21.46% | Matthew Harrison60% | $83 → $84 | Maintains | Overweight | Get Alert |
| 10/12/2021 | BMY | Buy Now | Bristol-Myers Squibb | $60.00 | 10% | Matthew Harrison60% | $71 → $66 | Maintains | Equal-Weight | Get Alert |
| 10/12/2021 | BIIB | Buy Now | Biogen | $143.09 | 212.39% | Matthew Harrison60% | $455 → $447 | Maintains | Overweight | Get Alert |
| 10/12/2021 | AMGN | Buy Now | Amgen | $319.93 | -26.55% | Matthew Harrison60% | $251 → $235 | Maintains | Equal-Weight | Get Alert |
| 10/12/2021 | ALVR | Buy Now | AlloVir | $9.67 | 396.38% | Matthew Harrison60% | $1081 → $1104 | Maintains | Overweight | Get Alert |
| 10/05/2021 | AVIR | Buy Now | Atea Pharmaceuticals | $3.17 | 1635.02% | Matthew Harrison60% | → $55 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 09/29/2021 | ALVR | Buy Now | AlloVir | $9.67 | 2226.78% | Matthew Harrison60% | $4025 → $5175 | Maintains | Overweight | Get Alert |
| 09/07/2021 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -8.87% | Matthew Harrison60% | $576 → $606 | Maintains | Equal-Weight | Get Alert |
| 09/07/2021 | MRNA | Buy Now | Moderna | $33.70 | 900% | Matthew Harrison60% | $190 → $337 | Maintains | Equal-Weight | Get Alert |
| 09/07/2021 | CERE | Buy Now | Cerevel Therapeutics Hldg | — | — | Matthew Harrison60% | $27 → $39 | Maintains | Overweight | Get Alert |
| 09/07/2021 | ADCT | Buy Now | ADC Therapeutics | $1.83 | 2468.31% | Matthew Harrison60% | $51 → $47 | Maintains | Overweight | Get Alert |
| 09/07/2021 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | -60.56% | Matthew Harrison60% | → $202 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 09/07/2021 | ARGX | Buy Now | argenx | $610.00 | -42.46% | Matthew Harrison60% | $332 → $351 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 09/07/2021 | JNJ | Buy Now | Johnson & Johnson | $164.25 | 13.85% | Matthew Harrison60% | → $187 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 09/07/2021 | MRK | Buy Now | Merck & Co | $94.90 | -10.43% | Matthew Harrison60% | $90 → $85 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 09/07/2021 | GMAB | Buy Now | Genmab | $20.20 | 83.17% | Matthew Harrison60% | → $37 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 09/07/2021 | AMGN | Buy Now | Amgen | $319.93 | -21.54% | Matthew Harrison60% | $280 → $251 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 08/31/2021 | ADGI | Buy Now | Adagio Therapeutics | — | — | Matthew Harrison60% | → $33 | Initiates | → Equal-Weight | Get Alert |
| 08/24/2021 | TNYA | Buy Now | Tenaya Therapeutics | $0.67 | 4508.98% | Matthew Harrison60% | → $31 | Initiates | → Overweight | Get Alert |
| 08/18/2021 | TSHA | Buy Now | Taysha Gene Therapies | $1.81 | 2059.83% | Matthew Harrison60% | $43 → $39 | Maintains | Overweight | Get Alert |
| 08/18/2021 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | Matthew Harrison60% | $20 → $19 | Maintains | Overweight | Get Alert |
| 08/18/2021 | AVIR | Buy Now | Atea Pharmaceuticals | $3.17 | 1067.19% | Matthew Harrison60% | $35 → $37 | Maintains | Overweight | Get Alert |
| 08/18/2021 | ALVR | Buy Now | AlloVir | $9.67 | 386.04% | Matthew Harrison60% | $1150 → $1081 | Maintains | Overweight | Get Alert |
| 08/16/2021 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | 23.09% | Matthew Harrison60% | $93 → $90 | Maintains | Equal-Weight | Get Alert |
| 08/16/2021 | RPRX | Buy Now | Royalty Pharma | $33.66 | 36.66% | Matthew Harrison60% | $51 → $46 | Maintains | Equal-Weight | Get Alert |
| 08/16/2021 | OGN | Buy Now | Organon | $15.71 | 122.79% | Matthew Harrison60% | $33 → $35 | Maintains | Equal-Weight | Get Alert |
| 08/16/2021 | DNLI | Buy Now | Denali Therapeutics | $14.51 | 582.29% | Matthew Harrison60% | $100 → $99 | Maintains | Overweight | Get Alert |
| 08/16/2021 | BGNE | Buy Now | BeiGene | — | — | Matthew Harrison60% | $409 → $407 | Maintains | Overweight | Get Alert |
| 08/11/2021 | FULC | Buy Now | Fulcrum Therapeutics | $3.02 | 1025.83% | Matthew Harrison60% | → $34 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 08/11/2021 | IMRA | Buy Now | Imara | — | — | Matthew Harrison60% | $132 → $48 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 08/05/2021 | LLY | Buy Now | Eli Lilly | $821.00 | -66.5% | Matthew Harrison60% | $207 → $275 | Maintains | Overweight | Get Alert |
| 08/04/2021 | LLY | Buy Now | Eli Lilly | $821.00 | -66.5% | Matthew Harrison60% | $207 → $275 | Maintains | Overweight | Get Alert |
| 08/03/2021 | ARGX | Buy Now | argenx | $610.00 | -45.57% | Matthew Harrison60% | $324 → $332 | Maintains | Overweight | Get Alert |
| 07/30/2021 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | -60.56% | Matthew Harrison60% | $205 → $202 | Maintains | Equal-Weight | Get Alert |
| 07/29/2021 | PFE | Buy Now | Pfizer | $26.30 | 71.09% | Matthew Harrison60% | $42 → $45 | Maintains | Equal-Weight | Get Alert |
| 07/29/2021 | BMY | Buy Now | Bristol-Myers Squibb | $60.00 | 18.33% | Matthew Harrison60% | $62 → $71 | Maintains | Equal-Weight | Get Alert |
| 07/23/2021 | BIIB | Buy Now | Biogen | $143.09 | 217.98% | Matthew Harrison60% | $453 → $455 | Maintains | Overweight | Get Alert |
| 07/16/2021 | SGTX | Buy Now | Sigilon Therapeutics | — | — | Matthew Harrison60% | $585 → $117 | Maintains | Equal-Weight | Get Alert |
| 07/16/2021 | SGEN | Buy Now | Seagen | — | — | Matthew Harrison60% | $173 → $167 | Maintains | Equal-Weight | Get Alert |
| 07/16/2021 | BLUE | Buy Now | bluebird bio | $3.94 | 788.32% | Matthew Harrison60% | $720 → $700 | Maintains | Equal-Weight | Get Alert |
| 07/16/2021 | BHVN | Buy Now | Biohaven | $28.51 | 275.31% | Matthew Harrison60% | $69 → $107 | Maintains | Equal-Weight | Get Alert |
| 07/16/2021 | BIIB | Buy Now | Biogen | $143.09 | 216.58% | Matthew Harrison60% | $455 → $453 | Maintains | Overweight | Get Alert |
| 07/16/2021 | AMGN | Buy Now | Amgen | $319.93 | -12.48% | Matthew Harrison60% | $278 → $280 | Maintains | Overweight | Get Alert |
| 07/16/2021 | ALEC | Buy Now | Alector | $1.32 | 4218.18% | Matthew Harrison60% | $33 → $57 | Maintains | Overweight | Get Alert |
| 07/16/2021 | ADCT | Buy Now | ADC Therapeutics | $1.83 | 2686.89% | Matthew Harrison60% | $53 → $51 | Maintains | Overweight | Get Alert |
| 07/16/2021 | ADAG | Buy Now | Adagene | $1.81 | 1723.2% | Matthew Harrison60% | $34 → $33 | Maintains | Overweight | Get Alert |
| 07/12/2021 | LYEL | Buy Now | Lyell Immunopharma | $0.57 | 4320.08% | Matthew Harrison60% | → $25 | Initiates | → Overweight | Get Alert |
| 06/24/2021 | TV | Buy Now | Grupo Televisa | $1.72 | 1004.27% | Matthew Harrison60% | → $19 | Initiates | → Buy | Get Alert |
| 06/23/2021 | CNTA | Buy Now | Centessa Pharmaceuticals | $16.51 | 124.11% | Matthew Harrison60% | → $37 | Initiates | → Overweight | Get Alert |
| 06/22/2021 | CNTA | Buy Now | Centessa Pharmaceuticals | $16.51 | 124.11% | Matthew Harrison60% | → $37 | Initiates | → Overweight | Get Alert |
| 06/18/2021 | CERE | Buy Now | Cerevel Therapeutics Hldg | — | — | Matthew Harrison60% | → $27 | Initiates | → Overweight | Get Alert |
| 06/11/2021 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | -59.98% | Matthew Harrison60% | $254 → $205 | Maintains | Equal-Weight | Get Alert |
| 06/08/2021 | BIIB | Buy Now | Biogen | $143.09 | 217.98% | Matthew Harrison60% | $343 → $455 | Maintains | Overweight | Get Alert |
| 06/03/2021 | BGNE | Buy Now | BeiGene | — | — | Matthew Harrison60% | $357 → $409 | Maintains | Overweight | Get Alert |
| 06/03/2021 | AVIR | Buy Now | Atea Pharmaceuticals | $3.17 | 1004.1% | Matthew Harrison60% | $82 → $35 | Maintains | Overweight | Get Alert |
| 05/25/2021 | VACC | Buy Now | Vaccitech | — | — | Matthew Harrison60% | → $22 | Initiates | → Overweight | Get Alert |
| 05/18/2021 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | Matthew Harrison60% | $21 → $20 | Maintains | Overweight | Get Alert |
| 05/18/2021 | BHVN | Buy Now | Biohaven | $28.51 | 142.02% | Matthew Harrison60% | $76 → $69 | Maintains | Equal-Weight | Get Alert |
| 05/18/2021 | ARGX | Buy Now | argenx | $610.00 | -46.89% | Matthew Harrison60% | $321 → $324 | Maintains | Overweight | Get Alert |
| 05/10/2021 | INSM | Buy Now | Insmed | $76.99 | -27.26% | Matthew Harrison60% | $58 → $56 | Maintains | Overweight | Get Alert |
| 05/10/2021 | GLPG | Buy Now | Galapagos | $25.84 | 356.66% | Matthew Harrison60% | $117 → $118 | Maintains | Overweight | Get Alert |
| 05/10/2021 | EDIT | Buy Now | Editas Medicine | $1.35 | 2640.74% | Matthew Harrison60% | $40 → $37 | Maintains | Underweight | Get Alert |
| 05/10/2021 | BGNE | Buy Now | BeiGene | — | — | Matthew Harrison60% | $375 → $357 | Maintains | Overweight | Get Alert |
| 05/10/2021 | ADCT | Buy Now | ADC Therapeutics | $1.83 | 2796.17% | Matthew Harrison60% | $55 → $53 | Maintains | Overweight | Get Alert |
| 05/07/2021 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -25.56% | Matthew Harrison60% | $477 → $495 | Maintains | Equal-Weight | Get Alert |
| 05/07/2021 | MRNA | Buy Now | Moderna | $33.70 | 463.8% | Matthew Harrison60% | $201 → $190 | Maintains | Equal-Weight | Get Alert |
| 05/05/2021 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.86 | 301.44% | Matthew Harrison60% | $170 → $156 | Maintains | Overweight | Get Alert |
| 05/03/2021 | EVLO | Buy Now | Evelo Biosciences | $0.00 | 2599900% | Matthew Harrison60% | $280 → $260 | Maintains | Equal-Weight | Get Alert |
| 04/30/2021 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | -50.41% | Matthew Harrison60% | $253 → $254 | Maintains | Equal-Weight | Get Alert |
| 04/30/2021 | GILD | Buy Now | Gilead Sciences | $106.96 | -22.4% | Matthew Harrison60% | $81 → $83 | Maintains | Overweight | Get Alert |
| 04/28/2021 | AMGN | Buy Now | Amgen | $319.93 | -13.1% | Matthew Harrison60% | $281 → $278 | Maintains | Overweight | Get Alert |
| 04/19/2021 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | -50.61% | Matthew Harrison60% | $251 → $253 | Maintains | Equal-Weight | Get Alert |
| 04/19/2021 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | 27.19% | Matthew Harrison60% | $95 → $93 | Maintains | Equal-Weight | Get Alert |
| 04/19/2021 | SAGE | Buy Now | Sage Therapeutics | $7.84 | 933.16% | Matthew Harrison60% | $87 → $81 | Maintains | Equal-Weight | Get Alert |
| 04/19/2021 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -28.27% | Matthew Harrison60% | $525 → $477 | Maintains | Equal-Weight | Get Alert |
| 04/19/2021 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.86 | 337.47% | Matthew Harrison60% | $175 → $170 | Maintains | Overweight | Get Alert |
| 04/19/2021 | LEGN | Buy Now | Legend Biotech | $38.39 | 30.24% | Matthew Harrison60% | $55 → $50 | Maintains | Overweight | Get Alert |
| 04/19/2021 | KOD | Buy Now | Kodiak Sciences | $3.24 | 3572.84% | Matthew Harrison60% | $133 → $119 | Maintains | Equal-Weight | Get Alert |
| 04/19/2021 | IMRA | Buy Now | Imara | — | — | Matthew Harrison60% | $136 → $132 | Maintains | Overweight | Get Alert |
| 04/19/2021 | GMAB | Buy Now | Genmab | $20.20 | 83.17% | Matthew Harrison60% | $41 → $37 | Maintains | Equal-Weight | Get Alert |
| 04/19/2021 | GILD | Buy Now | Gilead Sciences | $106.96 | -24.27% | Matthew Harrison60% | $87 → $81 | Maintains | Overweight | Get Alert |
| 04/19/2021 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 14.61% | Matthew Harrison60% | $85 → $82 | Maintains | Equal-Weight | Get Alert |
| 04/19/2021 | BLUE | Buy Now | bluebird bio | $3.94 | 813.71% | Matthew Harrison60% | $900 → $720 | Maintains | Equal-Weight | Get Alert |
| 04/19/2021 | BIIB | Buy Now | Biogen | $143.09 | 139.71% | Matthew Harrison60% | $351 → $343 | Maintains | Overweight | Get Alert |
| 04/19/2021 | BHVN | Buy Now | Biohaven | $28.51 | 166.57% | Matthew Harrison60% | $73 → $76 | Maintains | Equal-Weight | Get Alert |
| 04/19/2021 | ARGX | Buy Now | argenx | $610.00 | -47.38% | Matthew Harrison60% | $326 → $321 | Maintains | Overweight | Get Alert |
| 04/19/2021 | AMGN | Buy Now | Amgen | $319.93 | -12.17% | Matthew Harrison60% | $279 → $281 | Maintains | Overweight | Get Alert |
| 04/19/2021 | ALVR | Buy Now | AlloVir | $9.67 | 417.06% | Matthew Harrison60% | $1127 → $1150 | Maintains | Overweight | Get Alert |
| 04/19/2021 | ALEC | Buy Now | Alector | $1.32 | 2400% | Matthew Harrison60% | $31 → $33 | Maintains | Overweight | Get Alert |
| 04/13/2021 | TSHA | Buy Now | Taysha Gene Therapies | $1.81 | 2281.35% | Matthew Harrison60% | $30 → $43 | Maintains | Overweight | Get Alert |
| 04/06/2021 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | Matthew Harrison60% | $23 → $21 | Maintains | Overweight | Get Alert |
| 04/06/2021 | FRLN | Buy Now | Freeline Therapeutics | — | — | Matthew Harrison60% | $420 → $330 | Maintains | Overweight | Get Alert |
| 04/06/2021 | AVIR | Buy Now | Atea Pharmaceuticals | $3.17 | 2486.75% | Matthew Harrison60% | $49 → $82 | Maintains | Overweight | Get Alert |
| 03/23/2021 | AKRO | Buy Now | Akero Therapeutics | $43.53 | 44.73% | Matthew Harrison60% | $70 → $63 | Maintains | Overweight | Get Alert |
| 03/23/2021 | ADCT | Buy Now | ADC Therapeutics | $1.83 | 2905.46% | Matthew Harrison60% | $56 → $55 | Maintains | Overweight | Get Alert |
| 03/11/2021 | GLPG | Buy Now | Galapagos | $25.84 | 352.79% | Matthew Harrison60% | $129 → $117 | Maintains | Overweight | Get Alert |
| 03/08/2021 | TSHA | Buy Now | Taysha Gene Therapies | $1.81 | 1561.41% | Matthew Harrison60% | $29 → $30 | Maintains | Overweight | Get Alert |
| 03/08/2021 | RGNX | Buy Now | Regenxbio | $7.86 | 688.8% | Matthew Harrison60% | $67 → $62 | Maintains | Overweight | Get Alert |
| 03/08/2021 | KOD | Buy Now | Kodiak Sciences | $3.24 | 4004.94% | Matthew Harrison60% | $125 → $133 | Maintains | Equal-Weight | Get Alert |
| 03/08/2021 | KLDO | Buy Now | Kaleido Biosciences | $0.00 | 11999900% | Matthew Harrison60% | $13 → $12 | Maintains | Equal-Weight | Get Alert |
| 03/08/2021 | IMRA | Buy Now | Imara | — | — | Matthew Harrison60% | $140 → $136 | Maintains | Overweight | Get Alert |
| 03/08/2021 | FULC | Buy Now | Fulcrum Therapeutics | $3.02 | 297.35% | Matthew Harrison60% | $11 → $12 | Maintains | Equal-Weight | Get Alert |
| 03/08/2021 | ARGX | Buy Now | argenx | $610.00 | -46.56% | Matthew Harrison60% | $311 → $326 | Maintains | Overweight | Get Alert |
| 03/08/2021 | ADAG | Buy Now | Adagene | $1.81 | 1778.45% | Matthew Harrison60% | → $34 | Initiates | → Overweight | Get Alert |
| 03/05/2021 | AMGN | Buy Now | Amgen | $319.93 | -12.79% | Matthew Harrison60% | $277 → $279 | Maintains | Overweight | Get Alert |
| 03/02/2021 | SAGE | Buy Now | Sage Therapeutics | $7.84 | 1009.69% | Matthew Harrison60% | $83 → $87 | Maintains | Equal-Weight | Get Alert |
| 03/02/2021 | INSM | Buy Now | Insmed | $76.99 | -24.67% | Matthew Harrison60% | $55 → $58 | Maintains | Overweight | Get Alert |
| 03/02/2021 | EDIT | Buy Now | Editas Medicine | $1.35 | 2862.96% | Matthew Harrison60% | $45 → $40 | Maintains | Underweight | Get Alert |
| 03/02/2021 | PHVS | Buy Now | Pharvaris | $15.96 | 219.55% | Matthew Harrison60% | → $51 | Maintains | Overweight | Get Alert |
| 03/02/2021 | BOLT | Buy Now | Bolt Biotherapeutics | $0.40 | 11263.64% | Matthew Harrison60% | → $45 | Initiates | → Overweight | Get Alert |
| 03/02/2021 | BLUE | Buy Now | bluebird bio | $3.94 | 1042.13% | Matthew Harrison60% | $1000 → $900 | Maintains | Equal-Weight | Get Alert |
| 03/01/2021 | SANA | Buy Now | Sana Biotechnology | $2.33 | 1616.74% | Matthew Harrison60% | → $40 | Initiates | → Overweight | Get Alert |
| 02/26/2021 | MRNA | Buy Now | Moderna | $33.70 | 496.44% | Matthew Harrison60% | $215 → $201 | Maintains | Equal-Weight | Get Alert |
| 02/24/2021 | HBAN | Buy Now | Huntington Bancshares | $14.76 | 16.87% | Matthew Harrison60% | $16.25 → $17.25 | Maintains | Equal-Weight | Get Alert |
| 02/18/2021 | MRNA | Buy Now | Moderna | $33.70 | 537.98% | Matthew Harrison60% | $150 → $215 | Maintains | Equal-Weight | Get Alert |
| 02/12/2021 | SGEN | Buy Now | Seagen | — | — | Matthew Harrison60% | $177 → $173 | Maintains | Equal-Weight | Get Alert |
| 02/08/2021 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -21.05% | Matthew Harrison60% | $553 → $525 | Maintains | Equal-Weight | Get Alert |
| 02/05/2021 | GILD | Buy Now | Gilead Sciences | $106.96 | -18.66% | Matthew Harrison60% | $83 → $87 | Maintains | Overweight | Get Alert |
| 02/04/2021 | BIIB | Buy Now | Biogen | $143.09 | 145.3% | Matthew Harrison60% | $352 → $351 | Maintains | Overweight | Get Alert |
| 02/03/2021 | AMGN | Buy Now | Amgen | $319.93 | -13.42% | Matthew Harrison60% | $285 → $277 | Maintains | Overweight | Get Alert |
| 01/19/2021 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | -51% | Matthew Harrison60% | $249 → $251 | Maintains | Equal-Weight | Get Alert |
| 01/19/2021 | SGEN | Buy Now | Seagen | — | — | Matthew Harrison60% | $175 → $177 | Maintains | Equal-Weight | Get Alert |
| 01/19/2021 | RGNX | Buy Now | Regenxbio | $7.86 | 752.42% | Matthew Harrison60% | $51 → $67 | Maintains | Overweight | Get Alert |
| 01/19/2021 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -16.84% | Matthew Harrison60% | $527 → $553 | Maintains | Equal-Weight | Get Alert |
| 01/19/2021 | KLDO | Buy Now | Kaleido Biosciences | $0.00 | 12999900% | Matthew Harrison60% | $8 → $13 | Maintains | Equal-Weight | Get Alert |
| 01/19/2021 | EVLO | Buy Now | Evelo Biosciences | $0.00 | 2799900% | Matthew Harrison60% | $120 → $280 | Maintains | Equal-Weight | Get Alert |
| 01/19/2021 | BIIB | Buy Now | Biogen | $143.09 | 146% | Matthew Harrison60% | $357 → $352 | Maintains | Overweight | Get Alert |
| 01/19/2021 | BGNE | Buy Now | BeiGene | — | — | Matthew Harrison60% | $310 → $375 | Maintains | Overweight | Get Alert |
| 01/19/2021 | AMGN | Buy Now | Amgen | $319.93 | -10.92% | Matthew Harrison60% | $276 → $285 | Maintains | Overweight | Get Alert |
| 01/19/2021 | GMAB | Buy Now | Genmab | $20.20 | 102.97% | Matthew Harrison60% | → $41 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 01/19/2021 | GLPG | Buy Now | Galapagos | $25.84 | 399.23% | Matthew Harrison60% | $159 → $129 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 01/19/2021 | GILD | Buy Now | Gilead Sciences | $106.96 | -22.4% | Matthew Harrison60% | → $83 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 01/19/2021 | EDIT | Buy Now | Editas Medicine | $1.35 | 3233.33% | Matthew Harrison60% | $64 → $45 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 01/08/2021 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | 29.92% | Matthew Harrison60% | $182 → $95 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/29/2020 | SGTX | Buy Now | Sigilon Therapeutics | — | — | Matthew Harrison60% | → $585 | Initiates | → Equal-Weight | Get Alert |
| 12/16/2020 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.86 | 350.33% | Matthew Harrison60% | $91 → $175 | Maintains | Overweight | Get Alert |
| 12/16/2020 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -20.75% | Matthew Harrison60% | $602 → $527 | Maintains | Equal-Weight | Get Alert |
| 12/16/2020 | INSM | Buy Now | Insmed | $76.99 | -28.56% | Matthew Harrison60% | $42 → $55 | Maintains | Overweight | Get Alert |
| 12/16/2020 | GBT | Buy Now | Global Blood Therapeutics | — | — | Matthew Harrison60% | $67 → $45 | Maintains | Equal-Weight | Get Alert |
| 12/16/2020 | GMAB | Buy Now | Genmab | $20.20 | 102.97% | Matthew Harrison60% | $37 → $41 | Maintains | Overweight | Get Alert |
| 12/16/2020 | EDIT | Buy Now | Editas Medicine | $1.35 | 4640.74% | Matthew Harrison60% | $30 → $64 | Maintains | Equal-Weight | Get Alert |
| 12/16/2020 | DNLI | Buy Now | Denali Therapeutics | $14.51 | 589.18% | Matthew Harrison60% | $75 → $100 | Maintains | Overweight | Get Alert |
| 12/16/2020 | BHVN | Buy Now | Biohaven | $28.51 | 156.05% | Matthew Harrison60% | $63 → $73 | Maintains | Equal-Weight | Get Alert |
| 12/16/2020 | ARGX | Buy Now | argenx | $610.00 | -49.02% | Matthew Harrison60% | $295 → $311 | Maintains | Overweight | Get Alert |
| 12/16/2020 | AMGN | Buy Now | Amgen | $319.93 | -13.73% | Matthew Harrison60% | $275 → $276 | Maintains | Overweight | Get Alert |
| 12/16/2020 | ADCT | Buy Now | ADC Therapeutics | $1.83 | 2960.11% | Matthew Harrison60% | $52 → $56 | Maintains | Overweight | Get Alert |
| 12/16/2020 | MRNA | Buy Now | Moderna | $33.70 | 345.1% | Matthew Harrison60% | $100 → $150 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/01/2020 | SAGE | Buy Now | Sage Therapeutics | $7.84 | 958.67% | Matthew Harrison60% | $85 → $83 | Maintains | Equal-Weight | Get Alert |
| 11/30/2020 | ABBV | Buy Now | AbbVie | $214.59 | -44.08% | Matthew Harrison60% | $108 → $120 | Maintains | Overweight | Get Alert |
| 11/24/2020 | AVIR | Buy Now | Atea Pharmaceuticals | $3.17 | 1445.74% | Matthew Harrison60% | → $49 | Initiates | → Overweight | Get Alert |
| 11/16/2020 | SAGE | Buy Now | Sage Therapeutics | $7.84 | 984.18% | Matthew Harrison60% | → $85 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/16/2020 | KOD | Buy Now | Kodiak Sciences | $3.24 | 3758.02% | Matthew Harrison60% | → $125 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/11/2020 | RGNX | Buy Now | Regenxbio | $7.86 | 548.85% | Matthew Harrison60% | $55 → $51 | Maintains | Overweight | Get Alert |
| 11/11/2020 | MRNA | Buy Now | Moderna | $33.70 | 196.74% | Matthew Harrison60% | $90 → $100 | Maintains | Overweight | Get Alert |
| 11/11/2020 | INSM | Buy Now | Insmed | $76.99 | -45.45% | Matthew Harrison60% | $38 → $42 | Maintains | Overweight | Get Alert |
| 11/11/2020 | INVA | Buy Now | Innoviva | $17.28 | -42.13% | Matthew Harrison60% | $8 → $10 | Maintains | Underweight | Get Alert |
| 11/11/2020 | EVLO | Buy Now | Evelo Biosciences | $0.00 | 1199900% | Matthew Harrison60% | $160 → $120 | Maintains | Equal-Weight | Get Alert |
| 11/11/2020 | EDIT | Buy Now | Editas Medicine | $1.35 | 2122.22% | Matthew Harrison60% | $31 → $30 | Maintains | Equal-Weight | Get Alert |
| 11/11/2020 | DNLI | Buy Now | Denali Therapeutics | $14.51 | 416.88% | Matthew Harrison60% | $45 → $75 | Maintains | Overweight | Get Alert |
| 11/11/2020 | BLUE | Buy Now | bluebird bio | $3.94 | 1169.04% | Matthew Harrison60% | $1360 → $1000 | Maintains | Equal-Weight | Get Alert |
| 11/11/2020 | BGNE | Buy Now | BeiGene | — | — | Matthew Harrison60% | $270 → $310 | Maintains | Overweight | Get Alert |
| 11/11/2020 | ARGX | Buy Now | argenx | $610.00 | -51.64% | Matthew Harrison60% | $281 → $295 | Maintains | Overweight | Get Alert |
| 11/09/2020 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -9.47% | Matthew Harrison60% | $609 → $602 | Maintains | Equal-Weight | Get Alert |
| 11/06/2020 | GBT | Buy Now | Global Blood Therapeutics | — | — | Matthew Harrison60% | $68 → $67 | Maintains | Equal-Weight | Get Alert |
| 11/05/2020 | GMAB | Buy Now | Genmab | $20.20 | 83.17% | Matthew Harrison60% | $35 → $37 | Maintains | Overweight | Get Alert |
| 11/03/2020 | GILD | Buy Now | Gilead Sciences | $106.96 | -37.36% | Matthew Harrison60% | → $67 | Reinstates | → Equal-Weight | Get Alert |
| 10/30/2020 | SGEN | Buy Now | Seagen | — | — | Matthew Harrison60% | $167 → $175 | Maintains | Equal-Weight | Get Alert |
| 10/30/2020 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Matthew Harrison60% | $121 → $119 | Maintains | Equal-Weight | Get Alert |
| 10/29/2020 | AMGN | Buy Now | Amgen | $319.93 | -14.04% | Matthew Harrison60% | $273 → $275 | Maintains | Overweight | Get Alert |
| 10/28/2020 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.86 | 134.17% | Matthew Harrison60% | $89 → $91 | Maintains | Overweight | Get Alert |
| 10/22/2020 | BIIB | Buy Now | Biogen | $143.09 | 149.49% | Matthew Harrison60% | $355 → $357 | Maintains | Overweight | Get Alert |
| 10/19/2020 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | -51.39% | Matthew Harrison60% | $281 → $249 | Maintains | Equal-Weight | Get Alert |
| 10/19/2020 | TSHA | Buy Now | Taysha Gene Therapies | $1.81 | — | Matthew Harrison60% | — | Initiates | → Overweight | Get Alert |
| 10/13/2020 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | -45.14% | Matthew Harrison60% | $300 → $281 | Maintains | Equal-Weight | Get Alert |
| 10/13/2020 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.86 | 129.03% | Matthew Harrison60% | $87 → $89 | Maintains | Overweight | Get Alert |
| 10/13/2020 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -8.42% | Matthew Harrison60% | $611 → $609 | Maintains | Equal-Weight | Get Alert |
| 10/13/2020 | GBT | Buy Now | Global Blood Therapeutics | — | — | Matthew Harrison60% | $75 → $68 | Maintains | Equal-Weight | Get Alert |
| 10/13/2020 | GMAB | Buy Now | Genmab | $20.20 | 73.27% | Matthew Harrison60% | $32 → $35 | Maintains | Overweight | Get Alert |
| 10/13/2020 | GLPG | Buy Now | Galapagos | $25.84 | 515.33% | Matthew Harrison60% | $158 → $159 | Maintains | Equal-Weight | Get Alert |
| 10/13/2020 | EDIT | Buy Now | Editas Medicine | $1.35 | 2196.3% | Matthew Harrison60% | $32 → $31 | Maintains | Equal-Weight | Get Alert |
| 10/13/2020 | BHVN | Buy Now | Biohaven | $28.51 | 120.98% | Matthew Harrison60% | $57 → $63 | Maintains | Equal-Weight | Get Alert |
| 10/13/2020 | BIIB | Buy Now | Biogen | $143.09 | 148.1% | Matthew Harrison60% | $357 → $355 | Maintains | Overweight | Get Alert |
| 10/13/2020 | BGNE | Buy Now | BeiGene | — | — | Matthew Harrison60% | $241 → $270 | Maintains | Overweight | Get Alert |
| 10/13/2020 | AMGN | Buy Now | Amgen | $319.93 | -14.67% | Matthew Harrison60% | $281 → $273 | Maintains | Overweight | Get Alert |
| 10/13/2020 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Matthew Harrison60% | $120 → $121 | Maintains | Equal-Weight | Get Alert |
| 10/13/2020 | ADCT | Buy Now | ADC Therapeutics | $1.83 | 2741.53% | Matthew Harrison60% | $53 → $52 | Maintains | Overweight | Get Alert |
| 09/15/2020 | SGEN | Buy Now | Seagen | — | — | Matthew Harrison60% | $160 → $167 | Maintains | Equal-Weight | Get Alert |
| 09/10/2020 | AKRO | Buy Now | Akero Therapeutics | $43.53 | 60.81% | Matthew Harrison60% | → $70 | Initiates | → Overweight | Get Alert |
| 09/01/2020 | FRLN | Buy Now | Freeline Therapeutics | — | — | Matthew Harrison60% | → $420 | Initiates | → Overweight | Get Alert |
| 08/24/2020 | SAGE | Buy Now | Sage Therapeutics | $7.84 | 1009.69% | Matthew Harrison60% | $85 → $87 | Maintains | Overweight | Get Alert |
| 08/24/2020 | DNLI | Buy Now | Denali Therapeutics | $14.51 | 210.13% | Matthew Harrison60% | $28 → $45 | Maintains | Overweight | Get Alert |
| 08/24/2020 | BHVN | Buy Now | Biohaven | $28.51 | 99.93% | Matthew Harrison60% | $60 → $57 | Maintains | Equal-Weight | Get Alert |
| 08/24/2020 | ALVR | Buy Now | AlloVir | $9.67 | 406.72% | Matthew Harrison60% | → $1127 | Initiates | → Overweight | Get Alert |
| 08/21/2020 | GLPG | Buy Now | Galapagos | $25.84 | 511.46% | Matthew Harrison60% | $221 → $158 | Maintains | Equal-Weight | Get Alert |
| 08/21/2020 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 18.8% | Matthew Harrison60% | $125 → $85 | Maintains | Equal-Weight | Get Alert |
| 08/18/2020 | UBX | Buy Now | Unity Biotechnology | $1.81 | 176.17% | Matthew Harrison60% | → $50 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 08/14/2020 | BMY | Buy Now | Bristol-Myers Squibb | $60.00 | 11.67% | Matthew Harrison60% | $66 → $67 | Maintains | Overweight | Get Alert |
| 08/13/2020 | GMAB | Buy Now | Genmab | $20.20 | 58.42% | Matthew Harrison60% | $30 → $32 | Maintains | Overweight | Get Alert |
| 08/12/2020 | BMY | Buy Now | Bristol-Myers Squibb | $60.00 | 10% | Matthew Harrison60% | $64 → $66 | Maintains | Overweight | Get Alert |
| 08/12/2020 | FULC | Buy Now | Fulcrum Therapeutics | $3.02 | 264.24% | Matthew Harrison60% | $29 → $11 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 08/10/2020 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | 148.91% | Matthew Harrison60% | $172 → $182 | Maintains | Overweight | Get Alert |
| 08/10/2020 | RGNX | Buy Now | Regenxbio | $7.86 | 599.75% | Matthew Harrison60% | $56 → $55 | Maintains | Overweight | Get Alert |
| 08/10/2020 | KLDO | Buy Now | Kaleido Biosciences | $0.00 | 7999900% | Matthew Harrison60% | $7 → $8 | Maintains | Equal-Weight | Get Alert |
| 08/10/2020 | INSM | Buy Now | Insmed | $76.99 | -50.64% | Matthew Harrison60% | $35 → $38 | Maintains | Overweight | Get Alert |
| 08/10/2020 | IMMU | Buy Now | Immunomedics | — | — | Matthew Harrison60% | $32 → $40 | Maintains | Equal-Weight | Get Alert |
| 08/10/2020 | GLPG | Buy Now | Galapagos | $25.84 | 755.26% | Matthew Harrison60% | $224 → $221 | Maintains | Equal-Weight | Get Alert |
| 08/10/2020 | EDIT | Buy Now | Editas Medicine | $1.35 | 2270.37% | Matthew Harrison60% | $27 → $32 | Maintains | Equal-Weight | Get Alert |
| 08/10/2020 | BLUE | Buy Now | bluebird bio | $3.94 | 1625.89% | Matthew Harrison60% | $1460 → $1360 | Maintains | Equal-Weight | Get Alert |
| 08/10/2020 | BGNE | Buy Now | BeiGene | — | — | Matthew Harrison60% | $235 → $241 | Maintains | Overweight | Get Alert |
| 08/10/2020 | ARGX | Buy Now | argenx | $610.00 | -53.93% | Matthew Harrison60% | $258 → $281 | Maintains | Overweight | Get Alert |
| 08/06/2020 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -8.11% | Matthew Harrison60% | $619 → $611 | Maintains | Equal-Weight | Get Alert |
| 07/31/2020 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.86 | 123.88% | Matthew Harrison60% | $88 → $87 | Maintains | Overweight | Get Alert |
| 07/31/2020 | SGEN | Buy Now | Seagen | — | — | Matthew Harrison60% | $149 → $160 | Maintains | Equal-Weight | Get Alert |
| 07/31/2020 | GILD | Buy Now | Gilead Sciences | $106.96 | -26.14% | Matthew Harrison60% | $80 → $79 | Maintains | Equal-Weight | Get Alert |
| 07/29/2020 | AMGN | Buy Now | Amgen | $319.93 | -12.17% | Matthew Harrison60% | $285 → $281 | Maintains | Overweight | Get Alert |
| 07/27/2020 | BIIB | Buy Now | Biogen | $143.09 | 149.49% | Matthew Harrison60% | $263 → $357 | Upgrade | Underweight → Overweight | Get Alert |
| 07/21/2020 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | Matthew Harrison60% | → $23 | Initiates | → Overweight | Get Alert |
| 07/15/2020 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.86 | 126.45% | Matthew Harrison60% | $83 → $88 | Maintains | Overweight | Get Alert |
| 07/15/2020 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -6.91% | Matthew Harrison60% | $555 → $619 | Maintains | Equal-Weight | Get Alert |
| 07/15/2020 | KLDO | Buy Now | Kaleido Biosciences | $0.00 | 6999900% | Matthew Harrison60% | $8 → $7 | Maintains | Equal-Weight | Get Alert |
| 07/15/2020 | GILD | Buy Now | Gilead Sciences | $106.96 | -25.2% | Matthew Harrison60% | $77 → $80 | Maintains | Equal-Weight | Get Alert |
| 07/15/2020 | GLPG | Buy Now | Galapagos | $25.84 | 766.87% | Matthew Harrison60% | $226 → $224 | Maintains | Equal-Weight | Get Alert |
| 07/15/2020 | BHVN | Buy Now | Biohaven | $28.51 | 110.45% | Matthew Harrison60% | $50 → $60 | Maintains | Equal-Weight | Get Alert |
| 07/15/2020 | BIIB | Buy Now | Biogen | $143.09 | 83.8% | Matthew Harrison60% | $301 → $263 | Maintains | Underweight | Get Alert |
| 07/15/2020 | BGNE | Buy Now | BeiGene | — | — | Matthew Harrison60% | $190 → $235 | Maintains | Overweight | Get Alert |
| 07/15/2020 | AMGN | Buy Now | Amgen | $319.93 | -10.92% | Matthew Harrison60% | $280 → $285 | Maintains | Overweight | Get Alert |
| 07/08/2020 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 74.7% | Matthew Harrison60% | → $125 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 07/08/2020 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | -41.43% | Matthew Harrison60% | $277 → $300 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 07/01/2020 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.86 | 113.59% | Matthew Harrison60% | $79 → $83 | Maintains | Overweight | Get Alert |
| 06/30/2020 | LEGN | Buy Now | Legend Biotech | $38.39 | 43.26% | Matthew Harrison60% | → $55 | Initiates | → Overweight | Get Alert |
| 06/09/2020 | ADCT | Buy Now | ADC Therapeutics | $1.83 | 2796.17% | Matthew Harrison60% | → $53 | Initiates | → Overweight | Get Alert |
| 06/04/2020 | ALEC | Buy Now | Alector | $1.32 | 2248.48% | Matthew Harrison60% | $29 → $31 | Maintains | Overweight | Get Alert |
| 05/28/2020 | BLUE | Buy Now | bluebird bio | $3.94 | 1752.79% | Matthew Harrison60% | $1380 → $1460 | Maintains | Equal-Weight | Get Alert |
| 05/28/2020 | BGNE | Buy Now | BeiGene | — | — | Matthew Harrison60% | $184 → $190 | Maintains | Overweight | Get Alert |
| 05/27/2020 | ARGX | Buy Now | argenx | $610.00 | -57.7% | Matthew Harrison60% | $180 → $258 | Maintains | Overweight | Get Alert |
| 05/21/2020 | EVLO | Buy Now | Evelo Biosciences | $0.00 | 1599900% | Matthew Harrison60% | → $160 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 05/21/2020 | KLDO | Buy Now | Kaleido Biosciences | $0.00 | 7999900% | Matthew Harrison60% | → $8 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 05/20/2020 | MRNA | Buy Now | Moderna | $33.70 | 167.06% | Matthew Harrison60% | $37 → $90 | Maintains | Overweight | Get Alert |
| 05/11/2020 | RGNX | Buy Now | Regenxbio | $7.86 | 612.47% | Matthew Harrison60% | $55 → $56 | Maintains | Overweight | Get Alert |
| 05/11/2020 | EDIT | Buy Now | Editas Medicine | $1.35 | 1900% | Matthew Harrison60% | $30 → $27 | Maintains | Equal-Weight | Get Alert |
| 05/11/2020 | BHVN | Buy Now | Biohaven | $28.51 | 75.38% | Matthew Harrison60% | $46 → $50 | Maintains | Equal-Weight | Get Alert |
| 05/08/2020 | PTLA | Buy Now | Portola Pharmaceuticals | — | — | Matthew Harrison60% | $14 → $18 | Maintains | Equal-Weight | Get Alert |
| 05/07/2020 | IMMU | Buy Now | Immunomedics | — | — | Matthew Harrison60% | $22 → $32 | Maintains | Equal-Weight | Get Alert |
| 05/07/2020 | GBT | Buy Now | Global Blood Therapeutics | — | — | Matthew Harrison60% | $70 → $75 | Maintains | Equal-Weight | Get Alert |
| 05/07/2020 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Matthew Harrison60% | $116 → $120 | Maintains | Equal-Weight | Get Alert |
| 05/06/2020 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -16.54% | Matthew Harrison60% | $409 → $555 | Maintains | Equal-Weight | Get Alert |
| 05/04/2020 | SGEN | Buy Now | Seagen | — | — | Matthew Harrison60% | $111 → $149 | Maintains | Equal-Weight | Get Alert |
| 05/01/2020 | GILD | Buy Now | Gilead Sciences | $106.96 | -28.01% | Matthew Harrison60% | $75 → $77 | Maintains | Equal-Weight | Get Alert |
| 05/01/2020 | AMGN | Buy Now | Amgen | $319.93 | -12.48% | Matthew Harrison60% | $267 → $280 | Maintains | Overweight | Get Alert |
| 04/30/2020 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | -45.92% | Matthew Harrison60% | $258 → $277 | Maintains | Overweight | Get Alert |
| 04/23/2020 | BIIB | Buy Now | Biogen | $143.09 | 110.36% | Matthew Harrison60% | $302 → $301 | Maintains | Underweight | Get Alert |
| 04/15/2020 | MRNA | Buy Now | Moderna | $33.70 | 9.79% | Matthew Harrison60% | $30 → $37 | Maintains | Overweight | Get Alert |
| 04/15/2020 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -38.49% | Matthew Harrison60% | $410 → $409 | Maintains | Equal-Weight | Get Alert |
| 04/15/2020 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | 135.23% | Matthew Harrison60% | $173 → $172 | Maintains | Overweight | Get Alert |
| 04/15/2020 | SGEN | Buy Now | Seagen | — | — | Matthew Harrison60% | $107 → $111 | Maintains | Equal-Weight | Get Alert |
| 04/15/2020 | UBX | Buy Now | Unity Biotechnology | $1.81 | 618.03% | Matthew Harrison60% | $140 → $130 | Maintains | Overweight | Get Alert |
| 04/15/2020 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | -49.63% | Matthew Harrison60% | $251 → $258 | Maintains | Overweight | Get Alert |
| 04/15/2020 | INSM | Buy Now | Insmed | $76.99 | -54.54% | Matthew Harrison60% | $50 → $35 | Maintains | Overweight | Get Alert |
| 04/15/2020 | IMMU | Buy Now | Immunomedics | — | — | Matthew Harrison60% | $19 → $22 | Maintains | Equal-Weight | Get Alert |
| 04/15/2020 | GBT | Buy Now | Global Blood Therapeutics | — | — | Matthew Harrison60% | $71 → $70 | Maintains | Equal-Weight | Get Alert |
| 04/15/2020 | GMAB | Buy Now | Genmab | $20.20 | 48.51% | Matthew Harrison60% | $31 → $30 | Maintains | Overweight | Get Alert |
| 04/15/2020 | GLPG | Buy Now | Galapagos | $25.84 | 774.61% | Matthew Harrison60% | $220 → $226 | Maintains | Equal-Weight | Get Alert |
| 04/15/2020 | DNLI | Buy Now | Denali Therapeutics | $14.51 | 92.97% | Matthew Harrison60% | $30 → $28 | Maintains | Overweight | Get Alert |
| 04/15/2020 | BLUE | Buy Now | bluebird bio | $3.94 | 1651.27% | Matthew Harrison60% | $1840 → $1380 | Maintains | Equal-Weight | Get Alert |
| 04/15/2020 | BHVN | Buy Now | Biohaven | $28.51 | 61.35% | Matthew Harrison60% | $49 → $46 | Maintains | Equal-Weight | Get Alert |
| 04/15/2020 | BGNE | Buy Now | BeiGene | — | — | Matthew Harrison60% | $210 → $184 | Maintains | Overweight | Get Alert |
| 04/15/2020 | AMGN | Buy Now | Amgen | $319.93 | -16.54% | Matthew Harrison60% | $277 → $267 | Maintains | Overweight | Get Alert |
| 04/15/2020 | ALEC | Buy Now | Alector | $1.32 | 2096.97% | Matthew Harrison60% | $27 → $29 | Maintains | Overweight | Get Alert |
| 04/15/2020 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Matthew Harrison60% | $127 → $116 | Maintains | Equal-Weight | Get Alert |
| 04/15/2020 | KOD | Buy Now | Kodiak Sciences | $3.24 | 2369.14% | Matthew Harrison60% | $82 → $80 | Maintains | Overweight | Get Alert |
| 04/06/2020 | IMRA | Buy Now | Imara | — | — | Matthew Harrison60% | $140 → $140 | Initiates | → Overweight | Get Alert |
| 03/17/2020 | HBAN | Buy Now | Huntington Bancshares | $14.76 | -11.92% | Matthew Harrison60% | $13.5 → $13 | Maintains | Equal-Weight | Get Alert |
| 03/05/2020 | HBAN | Buy Now | Huntington Bancshares | $14.76 | -3.46% | Matthew Harrison60% | $15.5 → $14.25 | Maintains | Equal-Weight | Get Alert |
| 03/03/2020 | SAGE | Buy Now | Sage Therapeutics | $7.84 | 1392.35% | Matthew Harrison60% | $125 → $117 | Maintains | Overweight | Get Alert |
| 03/03/2020 | RGNX | Buy Now | Regenxbio | $7.86 | 599.75% | Matthew Harrison60% | $58 → $55 | Maintains | Overweight | Get Alert |
| 03/03/2020 | IMMU | Buy Now | Immunomedics | — | — | Matthew Harrison60% | $17 → $19 | Maintains | Equal-Weight | Get Alert |
| 03/03/2020 | GBT | Buy Now | Global Blood Therapeutics | — | — | Matthew Harrison60% | $80 → $71 | Maintains | Equal-Weight | Get Alert |
| 03/03/2020 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 74.7% | Matthew Harrison60% | $120 → $125 | Maintains | Overweight | Get Alert |
| 03/03/2020 | FTSV | Buy Now | Forty Seven | — | — | Matthew Harrison60% | $45 → $95.5 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 02/26/2020 | GLPG | Buy Now | Galapagos | $25.84 | 751.39% | Matthew Harrison60% | $215 → $220 | Maintains | Equal-Weight | Get Alert |
| 02/26/2020 | BLUE | Buy Now | bluebird bio | $3.94 | 2235.03% | Matthew Harrison60% | $2000 → $1840 | Maintains | Equal-Weight | Get Alert |
| 02/20/2020 | GMAB | Buy Now | Genmab | $20.20 | 53.47% | Matthew Harrison60% | $30 → $31 | Maintains | Overweight | Get Alert |
| 02/07/2020 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -38.34% | Matthew Harrison60% | $411 → $410 | Maintains | Equal-Weight | Get Alert |
| 02/06/2020 | BIIB | Buy Now | Biogen | $143.09 | 111.06% | Matthew Harrison60% | $261 → $302 | Maintains | Underweight | Get Alert |
| 02/04/2020 | INSM | Buy Now | Insmed | $76.99 | -35.06% | Matthew Harrison60% | $37 → $50 | Maintains | Overweight | Get Alert |
| 01/31/2020 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | -51% | Matthew Harrison60% | $250 → $251 | Maintains | Overweight | Get Alert |
| 01/31/2020 | BIIB | Buy Now | Biogen | $143.09 | 82.4% | Matthew Harrison60% | $270 → $261 | Maintains | Underweight | Get Alert |
| 01/17/2020 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.86 | 98.15% | Matthew Harrison60% | $73 → $77 | Maintains | Overweight | Get Alert |
| 01/17/2020 | SGEN | Buy Now | Seagen | — | — | Matthew Harrison60% | $123 → $115 | Maintains | Equal-Weight | Get Alert |
| 01/17/2020 | RGNX | Buy Now | Regenxbio | $7.86 | 637.91% | Matthew Harrison60% | $55 → $58 | Maintains | Overweight | Get Alert |
| 01/17/2020 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -38.19% | Matthew Harrison60% | $387 → $411 | Maintains | Equal-Weight | Get Alert |
| 01/17/2020 | GBT | Buy Now | Global Blood Therapeutics | — | — | Matthew Harrison60% | $79 → $80 | Maintains | Equal-Weight | Get Alert |
| 01/17/2020 | BIIB | Buy Now | Biogen | $143.09 | 88.69% | Matthew Harrison60% | $262 → $270 | Maintains | Underweight | Get Alert |
| 01/17/2020 | ARGX | Buy Now | argenx | $610.00 | -70.49% | Matthew Harrison60% | $170 → $180 | Maintains | Overweight | Get Alert |
| 01/17/2020 | AMGN | Buy Now | Amgen | $319.93 | -13.42% | Matthew Harrison60% | $280 → $277 | Maintains | Overweight | Get Alert |
| 01/17/2020 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Matthew Harrison60% | $128 → $131 | Maintains | Equal-Weight | Get Alert |
| 01/17/2020 | BGNE | Buy Now | BeiGene | — | — | Matthew Harrison60% | → $210 | Reinstates | → Overweight | Get Alert |
| 01/06/2020 | INCY | Buy Now | Incyte | $60.00 | 38.33% | Matthew Harrison60% | $89 → $83 | Maintains | Equal-Weight | Get Alert |
| 12/24/2019 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | 136.6% | Matthew Harrison60% | $160 → $173 | Maintains | Overweight | Get Alert |
| 12/17/2019 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.86 | 87.85% | Matthew Harrison60% | $76 → $73 | Maintains | Overweight | Get Alert |
| 12/17/2019 | KOD | Buy Now | Kodiak Sciences | $3.24 | 2430.86% | Matthew Harrison60% | $33 → $82 | Maintains | Overweight | Get Alert |
| 12/17/2019 | GLPG | Buy Now | Galapagos | $25.84 | 732.04% | Matthew Harrison60% | $193 → $215 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/17/2019 | AMGN | Buy Now | Amgen | $319.93 | -12.48% | Matthew Harrison60% | → $280 | Reinstates | → Overweight | Get Alert |
| 12/17/2019 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Matthew Harrison60% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/10/2019 | FTSV | Buy Now | Forty Seven | — | — | Matthew Harrison60% | $17 → $45 | Maintains | Overweight | Get Alert |
| 12/10/2019 | SGEN | Buy Now | Seagen | — | — | Matthew Harrison60% | → $123 | Initiates | → Equal-Weight | Get Alert |
| 12/06/2019 | SAGE | Buy Now | Sage Therapeutics | $7.84 | 1494.39% | Matthew Harrison60% | $217 → $125 | Maintains | Overweight | Get Alert |
| 11/06/2019 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.86 | 95.57% | Matthew Harrison60% | $79 → $76 | Maintains | Overweight | Get Alert |
| 11/06/2019 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -41.8% | Matthew Harrison60% | $375 → $387 | Maintains | Equal-Weight | Get Alert |
| 11/01/2019 | BLUE | Buy Now | bluebird bio | $3.94 | 2438.07% | Matthew Harrison60% | $2080 → $2000 | Maintains | Equal-Weight | Get Alert |
| 10/31/2019 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | -51.19% | Matthew Harrison60% | $240 → $250 | Maintains | Overweight | Get Alert |
| 10/29/2019 | GLPG | Buy Now | Galapagos | $25.84 | 646.9% | Matthew Harrison60% | $200 → $193 | Maintains | Overweight | Get Alert |
| 10/28/2019 | ARGX | Buy Now | argenx | $610.00 | -72.13% | Matthew Harrison60% | $173 → $170 | Maintains | Overweight | Get Alert |
| 10/23/2019 | BIIB | Buy Now | Biogen | $143.09 | 83.1% | Matthew Harrison60% | $212 → $262 | Maintains | Underweight | Get Alert |
| 10/11/2019 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | 118.82% | Matthew Harrison60% | $220 → $160 | Maintains | Overweight | Get Alert |
| 10/11/2019 | RGNX | Buy Now | Regenxbio | $7.86 | 650.64% | Matthew Harrison60% | $85 → $59 | Maintains | Overweight | Get Alert |
| 10/11/2019 | BLUE | Buy Now | bluebird bio | $3.94 | 2539.59% | Matthew Harrison60% | $2720 → $2080 | Maintains | Equal-Weight | Get Alert |
| 10/11/2019 | BIIB | Buy Now | Biogen | $143.09 | 48.16% | Matthew Harrison60% | $211 → $212 | Maintains | Underweight | Get Alert |
| 10/11/2019 | BGNE | Buy Now | BeiGene | — | — | Matthew Harrison60% | $201 → $200 | Maintains | Overweight | Get Alert |
| 10/11/2019 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Matthew Harrison60% | $177 → $170 | Maintains | Overweight | Get Alert |
| 09/10/2019 | GLPG | Buy Now | Galapagos | $25.84 | 673.99% | Matthew Harrison60% | → $200 | Reinstates | → Overweight | Get Alert |
| 09/09/2019 | GLPG | Buy Now | Galapagos | $25.84 | 673.99% | Matthew Harrison60% | → $200 | Reinstates | → Overweight | Get Alert |
| 09/06/2019 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | -53.15% | Matthew Harrison60% | $215 → $240 | Maintains | Overweight | Get Alert |
| 08/12/2019 | BGNE | Buy Now | BeiGene | — | — | Matthew Harrison60% | $207 → $201 | Maintains | Overweight | Get Alert |
| 08/12/2019 | FULC | Buy Now | Fulcrum Therapeutics | $3.02 | 860.26% | Matthew Harrison60% | → $29 | Initiates | → Overweight | Get Alert |
| 08/12/2019 | GMAB | Buy Now | Genmab | $20.20 | — | Matthew Harrison60% | — | Initiates | → Overweight | Get Alert |
| 08/06/2019 | BLUE | Buy Now | bluebird bio | $3.94 | 3351.78% | Matthew Harrison60% | $2860 → $2720 | Maintains | Equal-Weight | Get Alert |
| 08/06/2019 | ARGX | Buy Now | argenx | $610.00 | -71.64% | Matthew Harrison60% | $143 → $173 | Maintains | Overweight | Get Alert |
| 08/02/2019 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.86 | 103.29% | Matthew Harrison60% | $83 → $79 | Maintains | Overweight | Get Alert |
| 07/22/2019 | BHVN | Buy Now | Biohaven | $28.51 | 78.88% | Matthew Harrison60% | $55 → $51 | Maintains | Equal-Weight | Get Alert |
| 07/15/2019 | BGNE | Buy Now | BeiGene | — | — | Matthew Harrison60% | $210 → $207 | Maintains | Overweight | Get Alert |
| 07/15/2019 | AMGN | Buy Now | Amgen | $319.93 | -35.3% | Matthew Harrison60% | $211 → $207 | Maintains | Overweight | Get Alert |
| 07/09/2019 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | 200.88% | Matthew Harrison60% | $165 → $220 | Maintains | Overweight | Get Alert |
| 05/14/2019 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | 125.66% | Matthew Harrison60% | $169 → $165 | Maintains | Overweight | Get Alert |
| 05/14/2019 | BHVN | Buy Now | Biohaven | $28.51 | 99.93% | Matthew Harrison60% | $55 → $57 | Maintains | Equal-Weight | Get Alert |
| 05/14/2019 | BGNE | Buy Now | BeiGene | — | — | Matthew Harrison60% | $200 → $210 | Maintains | Overweight | Get Alert |
| 05/08/2019 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -41.5% | Matthew Harrison60% | $420 → $389 | Maintains | Equal-Weight | Get Alert |
| 04/29/2019 | GLPG | Buy Now | Galapagos | $25.84 | 437.93% | Matthew Harrison60% | $138 → $139 | Maintains | Overweight | Get Alert |
| 04/09/2019 | BHVN | Buy Now | Biohaven | $28.51 | — | Matthew Harrison60% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 03/27/2019 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.86 | 113.59% | Matthew Harrison60% | $68 → $83 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 03/25/2019 | KLDO | Buy Now | Kaleido Biosciences | $0.00 | 16999900% | Matthew Harrison60% | → $17 | Initiates | → Overweight | Get Alert |
| 03/22/2019 | BIIB | Buy Now | Biogen | $143.09 | — | Matthew Harrison60% | — | Downgrade | Overweight → Underweight | Get Alert |
| 03/04/2019 | GBT | Buy Now | Global Blood Therapeutics | — | — | Matthew Harrison60% | $55 → $57 | Maintains | Equal-Weight | Get Alert |
| 03/04/2019 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | 131.13% | Matthew Harrison60% | $161 → $169 | Maintains | Overweight | Get Alert |
| 03/04/2019 | ALEC | Buy Now | Alector | $1.32 | 1945.45% | Matthew Harrison60% | → $27 | Initiates | → Overweight | Get Alert |
| 02/12/2019 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Matthew Harrison60% | $165 → $175 | Maintains | Overweight | Get Alert |
| 01/22/2019 | IMMU | Buy Now | Immunomedics | — | — | Matthew Harrison60% | $38 → $17 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 01/04/2019 | ARGX | Buy Now | argenx | $610.00 | -77.05% | Matthew Harrison60% | → $140 | Initiates | → Overweight | Get Alert |
| 01/02/2019 | MRNA | Buy Now | Moderna | $33.70 | -13.95% | Matthew Harrison60% | → $29 | Initiates | → Overweight | Get Alert |
| 12/19/2018 | AMGN | Buy Now | Amgen | $319.93 | -33.73% | Matthew Harrison60% | $213 → $212 | Maintains | Overweight | Get Alert |
| 12/19/2018 | BIIB | Buy Now | Biogen | $143.09 | 180.24% | Matthew Harrison60% | $394 → $401 | Maintains | Overweight | Get Alert |
| 12/19/2018 | BLUE | Buy Now | bluebird bio | $3.94 | 3072.59% | Matthew Harrison60% | $3700 → $2500 | Maintains | Equal-Weight | Get Alert |
| 12/19/2018 | CELG | Buy Now | Celgene | — | — | Matthew Harrison60% | $93 → $88 | Maintains | Equal-Weight | Get Alert |
| 12/19/2018 | GILD | Buy Now | Gilead Sciences | $106.96 | -19.59% | Matthew Harrison60% | $85 → $86 | Maintains | Equal-Weight | Get Alert |
| 12/19/2018 | GBT | Buy Now | Global Blood Therapeutics | — | — | Matthew Harrison60% | $54 → $55 | Maintains | Equal-Weight | Get Alert |
| 12/19/2018 | RGNX | Buy Now | Regenxbio | $7.86 | 981.42% | Matthew Harrison60% | $93 → $85 | Maintains | Overweight | Get Alert |
| 12/19/2018 | UBX | Buy Now | Unity Biotechnology | $1.81 | 1225.6% | Matthew Harrison60% | $250 → $240 | Maintains | Overweight | Get Alert |
| 12/19/2018 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | -59% | Matthew Harrison60% | $211 → $210 | Maintains | Overweight | Get Alert |
| 11/05/2018 | GLPG | Buy Now | Galapagos | $25.84 | 406.97% | Matthew Harrison60% | $127 → $131 | Maintains | Overweight | Get Alert |
| 11/05/2018 | BLUE | Buy Now | bluebird bio | $3.94 | 4595.43% | Matthew Harrison60% | $3720 → $3700 | Maintains | Equal-Weight | Get Alert |
| 11/05/2018 | IMMU | Buy Now | Immunomedics | — | — | Matthew Harrison60% | → $38 | Initiates | → Overweight | Get Alert |
| 10/31/2018 | AMGN | Buy Now | Amgen | $319.93 | -33.42% | Matthew Harrison60% | $212 → $213 | Maintains | Overweight | Get Alert |
| 10/29/2018 | KOD | Buy Now | Kodiak Sciences | $3.24 | 517.28% | Matthew Harrison60% | → $20 | Initiates | → Overweight | Get Alert |
| 10/15/2018 | BLUE | Buy Now | bluebird bio | $3.94 | 4620.81% | Matthew Harrison60% | $3800 → $3720 | Maintains | Equal-Weight | Get Alert |
| 10/12/2018 | EVLO | Buy Now | Evelo Biosciences | $0.00 | 5999900% | Matthew Harrison60% | $580 → $600 | Maintains | Overweight | Get Alert |
| 10/11/2018 | UMRX | Buy Now | Unum Therapeutics | — | — | Matthew Harrison60% | $20 → $21 | Maintains | Overweight | Get Alert |
| 10/11/2018 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -38.04% | Matthew Harrison60% | $409 → $412 | Maintains | Equal-Weight | Get Alert |
| 10/11/2018 | RDUS | Buy Now | Radius Health | $28.98 | 96.69% | Matthew Harrison60% | $59 → $57 | Maintains | Overweight | Get Alert |
| 10/11/2018 | PTLA | Buy Now | Portola Pharmaceuticals | — | — | Matthew Harrison60% | $34 → $32 | Maintains | Equal-Weight | Get Alert |
| 10/11/2018 | LOXO | Buy Now | Loxo Oncology | — | — | Matthew Harrison60% | $215 → $213 | Maintains | Overweight | Get Alert |
| 10/11/2018 | FTSV | Buy Now | Forty Seven | — | — | Matthew Harrison60% | $25 → $26 | Maintains | Overweight | Get Alert |
| 10/11/2018 | EVLO | Buy Now | Evelo Biosciences | $0.00 | 5999900% | Matthew Harrison60% | $580 → $600 | Maintains | Overweight | Get Alert |
| 10/11/2018 | BHVN | Buy Now | Biohaven | $28.51 | 64.85% | Matthew Harrison60% | $45 → $47 | Maintains | Overweight | Get Alert |
| 10/11/2018 | AMGN | Buy Now | Amgen | $319.93 | -33.73% | Matthew Harrison60% | $210 → $212 | Maintains | Overweight | Get Alert |
| 10/11/2018 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Matthew Harrison60% | $157 → $165 | Maintains | Overweight | Get Alert |
| 10/01/2018 | INSM | Buy Now | Insmed | $76.99 | -48.05% | Matthew Harrison60% | $39 → $40 | Maintains | Overweight | Get Alert |
| 09/11/2018 | BHVN | Buy Now | Biohaven | $28.51 | 57.84% | Matthew Harrison60% | $44 → $45 | Maintains | Overweight | Get Alert |
| 09/10/2018 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.86 | 136.75% | Matthew Harrison60% | → $92 | Assumes | → Equal-Weight | Get Alert |
| 09/10/2018 | CYTK | Buy Now | Cytokinetics | $43.48 | -77% | Matthew Harrison60% | → $10 | Assumes | → Equal-Weight | Get Alert |
| 08/13/2018 | PTLA | Buy Now | Portola Pharmaceuticals | — | — | Matthew Harrison60% | $45 → $34 | Maintains | Equal-Weight | Get Alert |
| 08/06/2018 | INSM | Buy Now | Insmed | $76.99 | -49.34% | Matthew Harrison60% | $37 → $39 | Maintains | Overweight | Get Alert |
| 08/06/2018 | GLPG | Buy Now | Galapagos | $25.84 | 391.49% | Matthew Harrison60% | $126 → $127 | Maintains | Overweight | Get Alert |
| 08/03/2018 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -38.49% | Matthew Harrison60% | $396 → $409 | Maintains | Equal-Weight | Get Alert |
| 08/03/2018 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 60.73% | Matthew Harrison60% | $113 → $115 | Maintains | Overweight | Get Alert |
| 08/01/2018 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | — | Matthew Harrison60% | — | Upgrade | Equal-Weight → Overweight | Get Alert |
| 08/01/2018 | CYTK | Buy Now | Cytokinetics | $43.48 | -79.3% | Matthew Harrison60% | $18 → $9 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 07/27/2018 | CELG | Buy Now | Celgene | — | — | Matthew Harrison60% | $91 → $93 | Maintains | Equal-Weight | Get Alert |
| 07/27/2018 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Matthew Harrison60% | $150 → $157 | Maintains | Overweight | Get Alert |
| 07/26/2018 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | -58.81% | Matthew Harrison60% | $207 → $211 | Maintains | Overweight | Get Alert |
| 07/26/2018 | GILD | Buy Now | Gilead Sciences | $106.96 | -20.53% | Matthew Harrison60% | $81 → $85 | Maintains | Equal-Weight | Get Alert |
| 07/25/2018 | BIIB | Buy Now | Biogen | $143.09 | 173.95% | Matthew Harrison60% | $366 → $392 | Maintains | Overweight | Get Alert |
| 07/23/2018 | FTSV | Buy Now | Forty Seven | — | — | Matthew Harrison60% | → $25 | Initiates | → Overweight | Get Alert |
| 07/13/2018 | RGNX | Buy Now | Regenxbio | $7.86 | 1070.48% | Matthew Harrison60% | $37 → $92 | Maintains | Overweight | Get Alert |
| 07/13/2018 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -40.45% | Matthew Harrison60% | $370 → $396 | Maintains | Equal-Weight | Get Alert |
| 07/13/2018 | GLPG | Buy Now | Galapagos | $25.84 | 387.62% | Matthew Harrison60% | $125 → $126 | Maintains | Overweight | Get Alert |
| 07/13/2018 | CELG | Buy Now | Celgene | — | — | Matthew Harrison60% | $90 → $91 | Maintains | Equal-Weight | Get Alert |
| 07/13/2018 | BHVN | Buy Now | Biohaven | $28.51 | 54.33% | Matthew Harrison60% | $39 → $44 | Maintains | Overweight | Get Alert |
| 07/13/2018 | BIIB | Buy Now | Biogen | $143.09 | 155.78% | Matthew Harrison60% | $369 → $366 | Maintains | Overweight | Get Alert |
| 07/13/2018 | AMGN | Buy Now | Amgen | $319.93 | -34.36% | Matthew Harrison60% | $200 → $210 | Maintains | Overweight | Get Alert |
| 06/20/2018 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | 122.92% | Matthew Harrison60% | $91 → $163 | Maintains | Equal-Weight | Get Alert |
| 06/04/2018 | EVLO | Buy Now | Evelo Biosciences | $0.00 | 5799900% | Matthew Harrison60% | → $580 | Initiates | → Overweight | Get Alert |
| 06/04/2018 | LOXO | Buy Now | Loxo Oncology | — | — | Matthew Harrison60% | $170 → $215 | Maintains | Overweight | Get Alert |
| 05/29/2018 | UBX | Buy Now | Unity Biotechnology | $1.81 | 1280.83% | Matthew Harrison60% | → $250 | Initiates | → Overweight | Get Alert |
| 05/07/2018 | PTLA | Buy Now | Portola Pharmaceuticals | — | — | Matthew Harrison60% | $31 → $46 | Maintains | Equal-Weight | Get Alert |
| 05/07/2018 | CELG | Buy Now | Celgene | — | — | Matthew Harrison60% | $93 → $90 | Maintains | Equal-Weight | Get Alert |
| 05/04/2018 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | 24.45% | Matthew Harrison60% | $87 → $91 | Maintains | Equal-Weight | Get Alert |
| 05/04/2018 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -44.36% | Matthew Harrison60% | $400 → $370 | Maintains | Equal-Weight | Get Alert |
| 05/02/2018 | GILD | Buy Now | Gilead Sciences | $106.96 | -24.27% | Matthew Harrison60% | $85 → $81 | Maintains | Equal-Weight | Get Alert |
| 04/30/2018 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 57.93% | Matthew Harrison60% | $112 → $113 | Maintains | Overweight | Get Alert |
| 04/27/2018 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | -59.59% | Matthew Harrison60% | $200 → $207 | Maintains | Overweight | Get Alert |
| 04/25/2018 | BIIB | Buy Now | Biogen | $143.09 | 157.88% | Matthew Harrison60% | $365 → $369 | Maintains | Overweight | Get Alert |
| 04/25/2018 | AMGN | Buy Now | Amgen | $319.93 | -37.49% | Matthew Harrison60% | $205 → $200 | Maintains | Overweight | Get Alert |
| 04/23/2018 | UMRX | Buy Now | Unum Therapeutics | — | — | Matthew Harrison60% | → $20 | Initiates | → Overweight | Get Alert |
| 04/16/2018 | LOXO | Buy Now | Loxo Oncology | — | — | Matthew Harrison60% | — | Upgrade | Equal-Weight → Overweight | Get Alert |
| 04/13/2018 | CELG | Buy Now | Celgene | — | — | Matthew Harrison60% | → $93 | Reinstates | → Equal-Weight | Get Alert |
| 03/23/2018 | RDUS | Buy Now | Radius Health | $28.98 | 103.59% | Matthew Harrison60% | $61 → $59 | Maintains | Overweight | Get Alert |
| 03/21/2018 | INSM | Buy Now | Insmed | $76.99 | -49.34% | Matthew Harrison60% | → $39 | Initiates | → Overweight | Get Alert |
| 03/21/2018 | BLUE | Buy Now | bluebird bio | $3.94 | 5204.57% | Matthew Harrison60% | $3040 → $4180 | Maintains | Equal-Weight | Get Alert |
| 03/21/2018 | BGNE | Buy Now | BeiGene | — | — | Matthew Harrison60% | $93 → $200 | Maintains | Overweight | Get Alert |
| 03/21/2018 | LOXO | Buy Now | Loxo Oncology | — | — | Matthew Harrison60% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 03/21/2018 | GBT | Buy Now | Global Blood Therapeutics | — | — | Matthew Harrison60% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 03/21/2018 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | — | Matthew Harrison60% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 03/14/2018 | RGNX | Buy Now | Regenxbio | $7.86 | 345.29% | Matthew Harrison60% | $36 → $35 | Maintains | Overweight | Get Alert |
| 03/14/2018 | EDIT | Buy Now | Editas Medicine | $1.35 | 3085.19% | Matthew Harrison60% | $28 → $43 | Maintains | Equal-Weight | Get Alert |
| 03/06/2018 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | -12.47% | Matthew Harrison60% | $63 → $64 | Maintains | Overweight | Get Alert |
| 03/06/2018 | GBT | Buy Now | Global Blood Therapeutics | — | — | Matthew Harrison60% | $58 → $61 | Maintains | Overweight | Get Alert |
| 03/02/2018 | RDUS | Buy Now | Radius Health | $28.98 | 110.49% | Matthew Harrison60% | $57 → $61 | Maintains | Overweight | Get Alert |
| 03/01/2018 | PTLA | Buy Now | Portola Pharmaceuticals | — | — | Matthew Harrison60% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 02/26/2018 | BLUE | Buy Now | bluebird bio | $3.94 | 3757.87% | Matthew Harrison60% | $3020 → $3040 | Maintains | Equal-Weight | Get Alert |
| 02/23/2018 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 56.53% | Matthew Harrison60% | $115 → $112 | Maintains | Overweight | Get Alert |
| 02/22/2018 | PTLA | Buy Now | Portola Pharmaceuticals | — | — | Matthew Harrison60% | $74 → $65 | Maintains | Overweight | Get Alert |
| 02/21/2018 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.86 | 54.4% | Matthew Harrison60% | $57 → $60 | Maintains | Equal-Weight | Get Alert |
| 02/21/2018 | CYTK | Buy Now | Cytokinetics | $43.48 | -58.6% | Matthew Harrison60% | $17 → $18 | Maintains | Overweight | Get Alert |
| 02/09/2018 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -37.59% | Matthew Harrison60% | $401 → $415 | Maintains | Equal-Weight | Get Alert |
| 02/09/2018 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Matthew Harrison60% | $148 → $151 | Maintains | Overweight | Get Alert |
| 02/07/2018 | GILD | Buy Now | Gilead Sciences | $106.96 | -21.46% | Matthew Harrison60% | $87 → $84 | Maintains | Equal-Weight | Get Alert |
| 02/02/2018 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | -60.96% | Matthew Harrison60% | $198 → $200 | Maintains | Overweight | Get Alert |
| 02/02/2018 | AMGN | Buy Now | Amgen | $319.93 | -38.74% | Matthew Harrison60% | $204 → $196 | Maintains | Overweight | Get Alert |
| 01/29/2018 | RDUS | Buy Now | Radius Health | $28.98 | 96.69% | Matthew Harrison60% | → $57 | Initiates | → Overweight | Get Alert |
| 01/23/2018 | BIVV | Buy Now | Bioverativ | — | — | Matthew Harrison60% | — | Upgrade | Underweight → Equal-Weight | Get Alert |
| 01/02/2018 | DNLI | Buy Now | Denali Therapeutics | $14.51 | 72.29% | Matthew Harrison60% | → $25 | Initiates | → Overweight | Get Alert |
| 11/09/2017 | RGNX | Buy Now | Regenxbio | $7.86 | 332.57% | Matthew Harrison60% | → $34 | Reinstates | → Overweight | Get Alert |
| 11/09/2017 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -30.37% | Matthew Harrison60% | $490 → $463 | Maintains | Equal-Weight | Get Alert |
| 11/03/2017 | BLUE | Buy Now | bluebird bio | $3.94 | — | Matthew Harrison60% | — | Upgrade | Underweight → Equal-Weight | Get Alert |
| 10/27/2017 | CELG | Buy Now | Celgene | — | — | Matthew Harrison60% | — | Upgrade | Underweight → Equal-Weight | Get Alert |
| 10/26/2017 | AMGN | Buy Now | Amgen | $319.93 | -39.67% | Matthew Harrison60% | $196 → $193 | Maintains | Overweight | Get Alert |
| 10/23/2017 | CELG | Buy Now | Celgene | — | — | Matthew Harrison60% | $120 → $115 | Maintains | Underweight | Get Alert |
| 10/06/2017 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.86 | 82.71% | Matthew Harrison60% | $69 → $71 | Maintains | Equal-Weight | Get Alert |
| 10/06/2017 | PTLA | Buy Now | Portola Pharmaceuticals | — | — | Matthew Harrison60% | $75 → $81 | Maintains | Overweight | Get Alert |
| 10/06/2017 | INVA | Buy Now | Innoviva | $17.28 | -53.7% | Matthew Harrison60% | $7 → $8 | Maintains | Underweight | Get Alert |
| 10/06/2017 | GBT | Buy Now | Global Blood Therapeutics | — | — | Matthew Harrison60% | $51 → $56 | Maintains | Overweight | Get Alert |
| 10/06/2017 | GILD | Buy Now | Gilead Sciences | $106.96 | -22.4% | Matthew Harrison60% | $77 → $83 | Maintains | Equal-Weight | Get Alert |
| 10/06/2017 | GLPG | Buy Now | Galapagos | $25.84 | 376.01% | Matthew Harrison60% | $92 → $123 | Maintains | Overweight | Get Alert |
| 10/06/2017 | EDIT | Buy Now | Editas Medicine | $1.35 | 1974.07% | Matthew Harrison60% | $27 → $28 | Maintains | Equal-Weight | Get Alert |
| 10/06/2017 | CYTK | Buy Now | Cytokinetics | $43.48 | -42.5% | Matthew Harrison60% | $24 → $25 | Maintains | Overweight | Get Alert |
| 10/06/2017 | BIVV | Buy Now | Bioverativ | — | — | Matthew Harrison60% | $45 → $47 | Maintains | Underweight | Get Alert |
| 10/06/2017 | BGNE | Buy Now | BeiGene | — | — | Matthew Harrison60% | $87 → $95 | Maintains | Overweight | Get Alert |
| 10/06/2017 | AMGN | Buy Now | Amgen | $319.93 | -38.74% | Matthew Harrison60% | $189 → $196 | Maintains | Overweight | Get Alert |
| 10/06/2017 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -26.31% | Matthew Harrison60% | $450 → $490 | Maintains | Equal-Weight | Get Alert |
| 10/06/2017 | JUNO | Buy Now | Juno Therapeutics | — | — | Matthew Harrison60% | $27 → $43 | Maintains | Equal-Weight | Get Alert |
| 10/06/2017 | LOXO | Buy Now | Loxo Oncology | — | — | Matthew Harrison60% | $95 → $103 | Maintains | Overweight | Get Alert |
| 10/06/2017 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 63.52% | Matthew Harrison60% | $115 → $117 | Maintains | Overweight | Get Alert |
| 10/05/2017 | CELG | Buy Now | Celgene | — | — | Matthew Harrison60% | — | Downgrade | Equal-Weight → Underweight | Get Alert |
| 10/05/2017 | BIIB | Buy Now | Biogen | $143.09 | — | Matthew Harrison60% | — | Upgrade | Equal-Weight → Overweight | Get Alert |
| 10/03/2017 | BHVN | Buy Now | Biohaven | $28.51 | 33.29% | Matthew Harrison60% | $47 → $38 | Maintains | Overweight | Get Alert |
| 10/02/2017 | BLUE | Buy Now | bluebird bio | $3.94 | — | Matthew Harrison60% | — | Downgrade | Equal-Weight → Underweight | Get Alert |
| 10/02/2017 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | — | Matthew Harrison60% | — | Upgrade | Equal-Weight → Overweight | Get Alert |
| 09/25/2017 | BHVN | Buy Now | Biohaven | $28.51 | 64.85% | Matthew Harrison60% | $28 → $47 | Maintains | Overweight | Get Alert |
| 08/07/2017 | JUNO | Buy Now | Juno Therapeutics | — | — | Matthew Harrison60% | $26 → $27 | Maintains | Equal-Weight | Get Alert |
| 08/07/2017 | BLUE | Buy Now | bluebird bio | $3.94 | 2564.97% | Matthew Harrison60% | $2060 → $2100 | Maintains | Equal-Weight | Get Alert |
| 07/26/2017 | BIIB | Buy Now | Biogen | $143.09 | 117.35% | Matthew Harrison60% | $301 → $311 | Maintains | Equal-Weight | Get Alert |
| 07/20/2017 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | -54.87% | Matthew Harrison60% | $31 → $33 | Maintains | Equal-Weight | Get Alert |
| 07/10/2017 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -32.33% | Matthew Harrison60% | $405 → $450 | Maintains | Equal-Weight | Get Alert |
| 07/10/2017 | GBT | Buy Now | Global Blood Therapeutics | — | — | Matthew Harrison60% | $53 → $51 | Maintains | Overweight | Get Alert |
| 07/10/2017 | BLUE | Buy Now | bluebird bio | $3.94 | 2514.21% | Matthew Harrison60% | $2100 → $2060 | Maintains | Equal-Weight | Get Alert |
| 07/10/2017 | BIIB | Buy Now | Biogen | $143.09 | 110.36% | Matthew Harrison60% | $307 → $301 | Maintains | Equal-Weight | Get Alert |
| 07/10/2017 | AMGN | Buy Now | Amgen | $319.93 | -40.92% | Matthew Harrison60% | $184 → $189 | Maintains | Overweight | Get Alert |
| 07/10/2017 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Matthew Harrison60% | $138 → $141 | Maintains | Overweight | Get Alert |
| 05/25/2017 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Matthew Harrison60% | — | Upgrade | Equal-Weight → Overweight | Get Alert |
| 04/03/2017 | LOXO | Buy Now | Loxo Oncology | — | — | Matthew Harrison60% | → $59 | Initiates | → Overweight | Get Alert |
| 03/16/2017 | BIIB | Buy Now | Biogen | $143.09 | 113.15% | Matthew Harrison60% | $369 → $305 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 02/07/2017 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 53.74% | Matthew Harrison60% | → $110 | Initiates | → Overweight | Get Alert |
| 12/13/2016 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Matthew Harrison60% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/13/2016 | OPHT | Buy Now | Ophthotech | — | — | Matthew Harrison60% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 10/27/2016 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | — | Matthew Harrison60% | — | Initiates | → Equal-Weight | Get Alert |
| 08/19/2016 | PTLA | Buy Now | Portola Pharmaceuticals | — | — | Matthew Harrison60% | $61 → $28 | Maintains | Overweight | Get Alert |
| 08/17/2016 | BIIB | Buy Now | Biogen | $143.09 | 157.18% | Matthew Harrison60% | $385 → $368 | Maintains | Overweight | Get Alert |
| 07/28/2016 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | -72.86% | Matthew Harrison60% | $140 → $139 | Maintains | Overweight | Get Alert |
| 07/28/2016 | AMGN | Buy Now | Amgen | $319.93 | -37.8% | Matthew Harrison60% | $198 → $199 | Maintains | Overweight | Get Alert |
| 07/21/2016 | BIIB | Buy Now | Biogen | $143.09 | 169.06% | Matthew Harrison60% | $383 → $385 | Maintains | Overweight | Get Alert |
| 06/07/2016 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Matthew Harrison60% | $203 → $189 | Maintains | Overweight | Get Alert |
| 05/26/2016 | GILD | Buy Now | Gilead Sciences | $106.96 | -3.7% | Matthew Harrison60% | $107 → $103 | Maintains | Equal-Weight | Get Alert |
| 05/02/2016 | GLPG | Buy Now | Galapagos | $25.84 | 244.43% | Matthew Harrison60% | $92 → $89 | Maintains | Overweight | Get Alert |
| 02/29/2016 | BGNE | Buy Now | BeiGene | — | — | Matthew Harrison60% | — | Initiates | → Overweight | Get Alert |
| 02/29/2016 | EDIT | Buy Now | Editas Medicine | $1.35 | 1974.07% | Matthew Harrison60% | → $28 | Initiates | → Equal-Weight | Get Alert |
| 02/10/2016 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -34.43% | Matthew Harrison60% | $583 → $436 | Maintains | Equal-Weight | Get Alert |
| 12/15/2015 | AMGN | Buy Now | Amgen | $319.93 | — | Matthew Harrison60% | — | Upgrade | Equal-Weight → Overweight | Get Alert |
| 12/14/2015 | AMGN | Buy Now | Amgen | $319.93 | -39.67% | Matthew Harrison60% | $160 → $193 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 12/07/2015 | BLUE | Buy Now | bluebird bio | $3.94 | 1651.27% | Matthew Harrison60% | $2860 → $1380 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 10/05/2015 | BLUE | Buy Now | bluebird bio | $3.94 | 3529.44% | Matthew Harrison60% | → $2860 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 10/02/2015 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | — | Matthew Harrison60% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 10/02/2015 | GILD | Buy Now | Gilead Sciences | $106.96 | 18.74% | Matthew Harrison60% | → $127 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 10/02/2015 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | -71.11% | Matthew Harrison60% | $118 → $148 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 10/02/2015 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Matthew Harrison60% | $186 → $211 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 09/08/2015 | BLUE | Buy Now | bluebird bio | $3.94 | 3529.44% | Matthew Harrison60% | → $2860 | Initiates | → Equal-Weight | Get Alert |
| 09/08/2015 | GBT | Buy Now | Global Blood Therapeutics | — | — | Matthew Harrison60% | → $67 | Initiates | → Overweight | Get Alert |
| 08/04/2015 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -10.82% | Matthew Harrison60% | $520 → $593 | Maintains | Overweight | Get Alert |
| 07/27/2015 | BIIB | Buy Now | Biogen | $143.09 | 197.71% | Matthew Harrison60% | $520 → $426 | Maintains | Overweight | Get Alert |
| 07/27/2015 | CELG | Buy Now | Celgene | — | — | Matthew Harrison60% | $107 → $134 | Maintains | Equal-Weight | Get Alert |
| 06/30/2015 | JUNO | Buy Now | Juno Therapeutics | — | — | Matthew Harrison60% | $59 → $54 | Maintains | Equal-Weight | Get Alert |
| 06/08/2015 | GLPG | Buy Now | Galapagos | $25.84 | 182.51% | Matthew Harrison60% | → $73 | Initiates | → Overweight | Get Alert |
| 01/05/2015 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Matthew Harrison60% | — | Downgrade | Overweight → Equal-weight | Get Alert |
| 01/05/2015 | AMGN | Buy Now | Amgen | $319.93 | — | Matthew Harrison60% | — | Downgrade | Overweight → Equal-weight | Get Alert |
| 01/05/2015 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | — | Matthew Harrison60% | — | Upgrade | Equal-weight → Overweight | Get Alert |
| 12/29/2014 | GILD | Buy Now | Gilead Sciences | $106.96 | — | Matthew Harrison60% | — | Upgrade | → Overweight | Get Alert |
| 12/09/2014 | GILD | Buy Now | Gilead Sciences | $106.96 | -6.51% | Matthew Harrison60% | $81 → $100 | Maintains | Equal-Weight | Get Alert |
| 04/22/2014 | OPHT | Buy Now | Ophthotech Corp. | — | — | Matthew Harrison60% | $56 → $79 | Maintains | Overweight | Get Alert |
| 03/27/2014 | GILD | Buy Now | Gilead Sciences | $106.96 | -29.88% | Matthew Harrison60% | → $75 | Initiates | → Equal-Weight | Get Alert |
| 03/27/2014 | CELG | Buy Now | Celgene | — | — | Matthew Harrison60% | → $75 | Initiates | → Equal-Weight | Get Alert |
| 03/27/2014 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -51.88% | Matthew Harrison60% | → $320 | Initiates | → Equal-Weight | Get Alert |
| 03/27/2014 | AMGN | Buy Now | Amgen | $319.93 | -56.24% | Matthew Harrison60% | → $140 | Initiates | → Overweight | Get Alert |
| 03/27/2014 | BIIB | Buy Now | Biogen | $143.09 | 176.05% | Matthew Harrison60% | → $395 | Initiates | → Overweight | Get Alert |
| 03/04/2014 | PTLA | Buy Now | Portola Pharmaceuticals | — | — | Matthew Harrison60% | $33 → $40 | Maintains | Overweight | Get Alert |
| 10/21/2013 | OPHT | Buy Now | Ophthotech Corp. | — | — | Matthew Harrison60% | → $56 | Initiates | → Overweight | Get Alert |
| 06/17/2013 | PTLA | Buy Now | Portola Pharmaceuticals | — | — | Matthew Harrison60% | → $32 | Initiates | → Overweight | Get Alert |
| 04/22/2013 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | -82.23% | Matthew Harrison60% | $45 → $91 | Maintains | Equal-Weight | Get Alert |
| 04/22/2013 | GILD | Buy Now | Gilead Sciences | $106.96 | -39.23% | Matthew Harrison60% | $46 → $65 | Maintains | Overweight | Get Alert |
| 03/25/2013 | BIIB | Buy Now | Biogen | $143.09 | 31.39% | Matthew Harrison60% | $177 → $188 | Maintains | Overweight | Get Alert |
| 12/18/2012 | GILD | Buy Now | Gilead Sciences | $106.96 | -18.66% | Matthew Harrison60% | $35.5 → $43.5 | Maintains | Overweight | Get Alert |
| 11/12/2012 | CELG | Buy Now | Celgene | — | — | Matthew Harrison60% | $40.5 → $41.5 | Maintains | Overweight | Get Alert |
| 07/25/2012 | BIIB | Buy Now | Biogen | $143.09 | 4.83% | Matthew Harrison60% | $140 → $150 | Maintains | Overweight | Get Alert |
| 07/23/2012 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | -27.32% | Matthew Harrison60% | $43 → $52 | Maintains | Buy | Get Alert |
| 05/08/2012 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | -90.04% | Matthew Harrison60% | $28 → $51 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 04/27/2012 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Matthew Harrison60% | $96 → $99 | Maintains | Overweight | Get Alert |
| 03/19/2012 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | -94.14% | Matthew Harrison60% | → $30 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 02/10/2012 | BIIB | Buy Now | Biogen Idec | $143.09 | -2.16% | Matthew Harrison60% | → $140 | Initiates | → Overweight | Get Alert |
| 02/10/2012 | GILD | Buy Now | Gilead Sciences | $106.96 | -39.23% | Matthew Harrison60% | → $32.5 | Initiates | → Overweight | Get Alert |
| 02/10/2012 | CELG | Buy Now | Celgene | — | — | Matthew Harrison60% | → $42.5 | Initiates | → Overweight | Get Alert |
| 02/10/2012 | AMGN | Buy Now | Amgen | $319.93 | — | Matthew Harrison60% | — | Initiates | → Equal-Weight | Get Alert |
